2004 Annual Meeting | Poster Session 05

Date Thursday 04/29/04

Time 07:30 AM - 12:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Scientific Poster Session

Topic(s) Aging and Dementia, Cerebrovascular Disease and Interventional Neurology, Critical Care/Emergency Neurology/Trauma, Clinical Neurophysiology, Anterior Horn and Peripheral Nerve, MS and Related Diseases, Epilepsy, Movement Disorders, Headache and Pain, Infections/AIDS/Prion Disease, Muscle Disease/Neuromuscular Junction, Autonomic Disorders

CME Available No CME available

Event Timeline
07:30 AM - 12:00 PM	Abstract	001 - Clinical and Neuroradiological Features of Cerebral Cavernous Malformations Associated with Krit1 Mutations
07:30 AM - 12:00 PM	Abstract	002 - Endovascular Therapy of Complicated Intracranial Aneurysms of the Internal Carotid Artery Using Onyx[trade]. A Novel Save and Efficient Treatment Option?
07:30 AM - 12:00 PM	Abstract	003 - Do Early Ischemic Changes in CT Scan Predict Intracerebral Hemorrhage among Thrombolyis Treated Acute Ischemic Stroke Patients?
07:30 AM - 12:00 PM	Abstract	004 - TRACH Scale Accurately Predicts Need for Tracheostomy in Mechanically Ventilated Patients with Spontaneous Intracerebral Hemorrhage
07:30 AM - 12:00 PM	Abstract	005 - Microbleedings in Stroke
07:30 AM - 12:00 PM	Abstract	007 - Cerebral Hemorrhage after Treatment with Tissue Plasminogen Activator in Patients with Acute Stroke Is Associated with Elevated Prothrombin Time and Decreased Serum Fibrinogen Levels
07:30 AM - 12:00 PM	Abstract	008 - Risk Factors and Locations of Microbleeds in Patients with Primary Intracerebral Hemorrhage
07:30 AM - 12:00 PM	Abstract	010 - Increased White Blood Cells (WBC), Fibrinogen and C-Reactive Protein (CRP) in Acute Ischemic Stroke Have Long-Term Prognostic Value
07:30 AM - 12:00 PM	Abstract	011 - Frequency and Impact of Complications Following Hemicraniectomy
07:30 AM - 12:00 PM	Abstract	012 - Accuracy of Emergency Medical Services Dispatcher Identification of Ischemic Stroke
07:30 AM - 12:00 PM	Abstract	013 - Deterioration from Ischemic Hemispheric Swelling: Which Patient Develops Uncal Herniation ?
07:30 AM - 12:00 PM	Abstract	014 - Predictors of Mannitol-Induced Renal Insufficiency in a Neurological/Neurosurgical Intensive Care Unit
07:30 AM - 12:00 PM	Abstract	015 - Fever after Subarachnoid Hemorrhage Worsens Outcome
07:30 AM - 12:00 PM	Abstract	016 - Is Decompressive Hemicraniectomy after Massive Hemispheric Infarction of Any Use in Older Patients?
07:30 AM - 12:00 PM	Abstract	017 - Cranial Dystonia in Patients with Acute Brain Injury: A Demographic Study and a Pilot Trial Using Botulinum Toxin
07:30 AM - 12:00 PM	Abstract	018 - Clinical Outcome and Predictors of Mechanical Ventilation in Elderly Patients with Guillian Barre Syndrom
07:30 AM - 12:00 PM	Abstract	019 - Intracerebral and Intraventricular Hemorrhage as Predictors for In-Hospital Complications and Outcome in Patients with Subarachnoid Hemorrhage
07:30 AM - 12:00 PM	Abstract	020 - The Prevalence of Hyperglycemia in the Neuro-Intensive Care Unit and Its Effect on Length of Stay and Cost of Care
07:30 AM - 12:00 PM	Abstract	021 - Effect of a new Phospholipase A2 Inhibitor on Acute Brain Injury
07:30 AM - 12:00 PM	Abstract	022 - Effects of Mn Porphyrin Catalytic Antioxidants on Mouse Spinal Cord Compression (SCC) Injury
07:30 AM - 12:00 PM	Abstract	023 - Treatment with Bcl-220-34 Protects CA1 Hippocampal Neurons from Carbon Monoxide-Induced Injury
07:30 AM - 12:00 PM	Abstract	024 - Alterations in Free-Radical Mediated Injury Expression in Subarachnoid Hemorrhage
07:30 AM - 12:00 PM	Abstract	025 - The Value of Pulmonary Function Tests in Predicting Intubation in Myasthenic Crises
07:30 AM - 12:00 PM	Abstract	026 - Transcranial Doppler (TCD) Use in Management of Acute Cerebral Malaria
07:30 AM - 12:00 PM	Abstract	027 - Measuring Brain Function Post Cardiac Arrest: Implementing a Real-Time Cortical Injury Monitor (CIM)
07:30 AM - 12:00 PM	Abstract	028 - Post-Concussion Symptoms 6 Months after Mild Traumatic Brain Injury: A Controlled Study
07:30 AM - 12:00 PM	Abstract	029 - A Novel Insertional Mutation in the Connexin 32 Gene Causes CMTX with Unusual Elecetrophysiological Findings
07:30 AM - 12:00 PM	Abstract	030 - Electrophysiological Features of Demyelination in Sensory CIDP
07:30 AM - 12:00 PM	Abstract	031 - Dispersion of the Distal Compound Muscle Action Potential Improves Electrodiagnosis of Guillain-Barre Syndrome
07:30 AM - 12:00 PM	Abstract	032 - Are Clinical Features the Best Predictive Factors To Treat Patients with Suspected CIDP?
07:30 AM - 12:00 PM	Abstract	033 - Automated Autonomic Nervous System (ANS) Testing (ANSAR) Has Superior Sensitivity Compared to Nerve Conduction Studies (NCS) in the Evaluation of Small Fiber Peripheral Neuropathy (PN)
07:30 AM - 12:00 PM	Abstract	034 - Generalized Low Motor-Normal Sensory Conduction Responses: A Rare but Ominous EMG Pattern
07:30 AM - 12:00 PM	Abstract	035 - The Clinical and Electrophysiological Features of Pure Digital Neuropathies
07:30 AM - 12:00 PM	Abstract	036 - Sparing of the Second Lumbrical Compound Muscle Action Potential in Electrophysiologically Severe Carpal Tunnel Syndrome
07:30 AM - 12:00 PM	Abstract	037 - The Lumbrical-Interosseous Latency as a Useful Method for Diagnosis of Extreme and Minimal Carpal Tunnel Syndrome
07:30 AM - 12:00 PM	Abstract	038 - Nerve Conduction Study Results and Treatment Outcome in Suprascapular Neuropathy
07:30 AM - 12:00 PM	Abstract	039 - Electroneuromyography Tests: A Tool for the Genetic Diagnosis of Skeletal Muscle Channelopathies
07:30 AM - 12:00 PM	Abstract	040 - Nerve Conduction Studies in Genetic Mitochondrial Diseases
07:30 AM - 12:00 PM	Abstract	042 - Motor Nerve Ratios Distinguish Patients with Multifocal Motor Neuropathy from Amyotrophic Lateral Sclerosis
07:30 AM - 12:00 PM	Abstract	043 - Auditory Symptoms in Hemifacial Spasms - Electrodiagnostic Findings
07:30 AM - 12:00 PM	Abstract	044 - A Case of Stiff Person Syndrome Associated with an Invasive Thymoma
07:30 AM - 12:00 PM	Abstract	045 - Blood Flow Regulation in Physiologically Activated Human Brain: Effects of Decreased Lactate/Pyruvate Ratio
07:30 AM - 12:00 PM	Abstract	046 - Differences between Anterior and Posterior Circulation Intraoperative Monitoring during Aneurysm Coiling
07:30 AM - 12:00 PM	Abstract	047 - Human Vascular Morphology during Alcohol Intoxication: A Magnetic Resonance Angiograpy Study
07:30 AM - 12:00 PM	Abstract	048 - Cerebrospinal Fluid Chemokine Levels in Relapsing Neuromyelitis Optica and Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	049 - Soluble CD26 and CD30 Levels in CSF of Patients with Relapsing Neuromyelitis Optica
07:30 AM - 12:00 PM	Abstract	050 - Spinal Fluid Interleukin-6 Levels in Transverse Myelitis: Correlation with Nitric Oxide Generation and Clinical Disability
07:30 AM - 12:00 PM	Abstract	052 - Cerebrospinal Fluid Neurofilament Heavy Chain Levels in Acute Optic Neuritis and Multiple Sclerosis Patients Treated with Oral High-Dose Methylpredinolone
07:30 AM - 12:00 PM	Abstract	053 - Persistence of Plasma Cells in CSF Discriminates Multiple Sclerosis from Acute Infectious Diseases
07:30 AM - 12:00 PM	Abstract	054 - Serum S100B in Primary Progressive Multiple Sclerosis Patients Treated with Interferon-Beta-1A
07:30 AM - 12:00 PM	Abstract	055 - Dynamics of Neutralizing Anti-Interferon Antibodies in Multiple Sclerosis Patients during Interferon-Beta Therapy
07:30 AM - 12:00 PM	Abstract	056 - The T Cell Repertoire in CSF and Blood Suggests a Dominant Role of CD8+ T Cells in the Pathogenesis of MS
07:30 AM - 12:00 PM	Abstract	057 - Correlation of Subsets of CD8+ T Cell Limphocytes with Clinical and MRI Disease Activity in RRMS Patients
07:30 AM - 12:00 PM	Abstract	058 - Interferon-Beta Stabilizes Blood-Brain Barrier Characteristics of Cerebral Endothelial Cells In Vitro
07:30 AM - 12:00 PM	Abstract	059 - Interferon-[beta] Induces Transient Systemic Chemokine Release in Patients with Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	060 - IFN-b-1a Induces Dose-Dependent Increases in Soluble VCAM Levels in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	061 - Interferon b-1b Inhibits Transendothelial Migration of Monocyte-Endothelial Microparticle Complexes Associated with Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	062 - Death Receptor Signaling and Function in Human Blood-Brain Barrier Endothelial Cells
07:30 AM - 12:00 PM	Abstract	063 - Monocyte-Derived HLA-G, a Strong Inhibitor of Autologous CD4 T-Cell Activation, Is Upregulated by Interferon-Beta In Vitro and In Vivo: Rationale for the Therapy of Multiple Sclerosis?
07:30 AM - 12:00 PM	Abstract	064 - Polymorphisms in IFNAR1 and IFNAR2 Promoter and Coding Regions in Multiple Sclerosis Patients
07:30 AM - 12:00 PM	Abstract	065 - Cerebral X-Linked Adrenoleukodystrophy and Adrenomyeloneuropathy Phenotypes Segregate to Distinctive Peripheral Gene Expression Profiles
07:30 AM - 12:00 PM	Abstract	066 - APOE e4 Frequency in African-American MS Patients and Association with Disease Severity
07:30 AM - 12:00 PM	Abstract	067 - Variants of [beta]-Chemokines within 17q11 in Multiple Sclerosis
07:30 AM - 12:00 PM	Abstract	068 - Standard Anterior Temporal Lobectomy Does Not Resect the Entire Seizure Onset Area in Temporal Lobe Epilepsy with Normal MRI
07:30 AM - 12:00 PM	Abstract	069 - Systematic Review of the Long Term Outcome in Epilepsy Surgery
07:30 AM - 12:00 PM	Abstract	071 - A Presurgical History of Depression Is Associated with a Worse Postsurgical Seizure Outcome Following a Temporal Lobectomy
07:30 AM - 12:00 PM	Abstract	072 - Video-EEG Monitoring Is Unnecessary and Can Be Misleading in Seizures Symptomatic to Hypothalamic Hamartomas
07:30 AM - 12:00 PM	Abstract	073 - Effects of Seizures on Intracranial Pressure in Children Undergoing Invasive EEG Monitoring
07:30 AM - 12:00 PM	Abstract	074 - A Comparison of Autonomic Functions before and after Epilepsy Surgery
07:30 AM - 12:00 PM	Abstract	075 - Extratemporal Lobe Epilepsy in Children: Clinical, Neurophysiologic Features and 1 Year-Surgical Outcome
07:30 AM - 12:00 PM	Abstract	076 - Temporal Lobe Resection for Epilepsy in Language-Dominant Hemisphere with Normal Recent Memory
07:30 AM - 12:00 PM	Abstract	077 - Effect of High Frequency Stimulation of the Subthalamic Nucleus on Ipsilateral Neuronal Activity of the Substantia Nigra Pars Reticulata in Parkinsonian's Patients
07:30 AM - 12:00 PM	Abstract	078 - Surgical and Hardware Complications of Subthalamic Stimulation: A Series of 160 Procedures
07:30 AM - 12:00 PM	Abstract	079 - Mortality in Patients with Parkinson"s Disease Treated with High Frequency Stimulation of the Subthalamic Nucleus
07:30 AM - 12:00 PM	Abstract	080 - Practical and Ethical Challenges in Surgical Trials: Perspectives of Parkinson's Disease (PD) Researchers
07:30 AM - 12:00 PM	Abstract	081 - The North American Survey of Placement and Adjustment Techniques for Deep Brain Stimulation
07:30 AM - 12:00 PM	Abstract	082 - What"s in a "Smile?" Intra-Operative Observations of Contralateral Smiles Induced by Deep Brain Stimulation
07:30 AM - 12:00 PM	Abstract	083 - Quality of Life, Social Adjustment and Psychological Consequences of STN Stimulation in Parkinson Disease: A Prospective Study
07:30 AM - 12:00 PM	Abstract	084 - Subthalamic Nucleus Stimulation Improves Trunk Stiffness and Protective Arm Movements in Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	085 - Is Bilateral Stimulation of the Subthalamic Nucleus Less Effective in Parkinson's Disease When Procedure Is Made under General Anaesthesia [rArr] A Prospective Study of 75 Patients
07:30 AM - 12:00 PM	Abstract	086 - Suicides after Successful Deep Brain Stimulation for Movement Disorders
07:30 AM - 12:00 PM	Abstract	087 - Is Advanced Age a Poor Predictor of Motor Outcome for Subthalamic DBS in Parkinson"s Disease?
07:30 AM - 12:00 PM	Abstract	088 - Effect of Patient Age on Response to Subthalamic Nucleus or Globus Pallidus Deep Brain Stimulation for Parkinson"s Disease: Results from a Prospective, Randomized Study
07:30 AM - 12:00 PM	Abstract	089 - Effects of Subthalamic Nucleus Stimulation on Postural Sway in Parkinsonian Patients
07:30 AM - 12:00 PM	Abstract	090 - Temporal Course of the Motor Effects of Subthalamic DBS after Stopping Stimulation
07:30 AM - 12:00 PM	Abstract	091 - The Effects of Unilateral Subthalamic Nuclei Stimulation on Cognition in Patients with Parkinson's Disease
07:30 AM - 12:00 PM	Abstract	092 - Automating Recognition of Surgical Target in Deep Brain Stimulation
07:30 AM - 12:00 PM	Abstract	093 - Subcutaneous Apomorphine Infusion vs. STN-DBS: Clinical and Neuropsychological Follow-Up at 12 Months in Patients with Complicated PD
07:30 AM - 12:00 PM	Abstract	094 - Motor Improvement in Early Parkinson Disease under Treatment with Safinamide a New Neuroprotectant. Results from a Parallel Double Blind Placebo Controlled Multinational Study
07:30 AM - 12:00 PM	Abstract	095 - Rotigotine CDS Patch in Advanced-Stage, Idiopathic Parkinson"s Disease: A Parallel Group, Open-Label, Dose-Escalation Trial
07:30 AM - 12:00 PM	Abstract	096 - Piribedil Efficacy in Monotherapy (150 to 300mg/day) in De Novo Parkinsonian Patients: A 6-Month Analysis of the 2-Year Parkinson-Regain Study
07:30 AM - 12:00 PM	Abstract	097 - Elusive Levels of Circulating Trace Amines in Primary Headaches
07:30 AM - 12:00 PM	Abstract	098 - Nitric Oxide Mediated Cyclooxigenase-2 and Matrix Metalloprotenase-9 Expression in Animal Model of Migraine
07:30 AM - 12:00 PM	Abstract	099 - MEG Studies of Effectiveness of Migraine Medications
07:30 AM - 12:00 PM	Abstract	100 - Neural Networks Involved in the Pathophysiology of Chronic Migraine with Analgesic Overuse: A FDG-PET Study
07:30 AM - 12:00 PM	Abstract	101 - Thymidylate Synthase Promoter Tandem Repeat and MTHFD1 R653Q Allelic Variants Modify the Risk for Migraine Conferred by MTHFR C677T Polymorphism
07:30 AM - 12:00 PM	Abstract	104 - High-Frequency (600 Hz) Oscillations of Somatosensory Evoked Responses Reflecting Thalamo-Cortical Activity Are Decreased in Migraine Patients between Attacks
07:30 AM - 12:00 PM	Abstract	105 - The Interictal Habituation Deficit of the Nociceptive Blink Reflex Is Correlated with That of Visual Evoked Potentials in Migraine Patients : Indication for a Common Underlying Mechanism ?
07:30 AM - 12:00 PM	Abstract	106 - C-Fiber Function in Patients with Diabetes Mellitus and Painful Neuropathy Assessed by Microneurography
07:30 AM - 12:00 PM	Abstract	107 - Muscle Proton MRS in West Nile Virus Induced Paralysis
07:30 AM - 12:00 PM	Abstract	109 - West Nile Meningitis/ Encephalitis: Experience with Corticosteroid Therapy
07:30 AM - 12:00 PM	Abstract	112 - Histologically Verified Fungal Infections of Central Nervous System: Experience at a University Hospital in South India
07:30 AM - 12:00 PM	Abstract	113 - Ten Cases of Toxocara canis Myelitis: Re-Defining a Rare Entity That May Not Be Rare
07:30 AM - 12:00 PM	Abstract	114 - A Placebo-Controlled Study of Memantine for the Treatment of HIV-Associated Sensory Neuropathy
07:30 AM - 12:00 PM	Abstract	115 - Brain Morphometric Correlates of Cognitive Function in HIV Patients: Relationship to Disease Severity
07:30 AM - 12:00 PM	Abstract	116 - The Diagnositic Utility of the Subjective Peripheral Neuropathy Scale in Human Immunodeficiency Virus (HIV)-Associated Sensory Neuropathy
07:30 AM - 12:00 PM	Abstract	117 - Caudate Nucleus Neuronal Density and Cell Size, Density in HIV Disease: Relation to Cognitive Impairment
07:30 AM - 12:00 PM	Abstract	118 - Cognitive Safety of Interruption of HAART in HIV-1 Infection
07:30 AM - 12:00 PM	Abstract	119 - CSF Induced Mitochondrial Toxicity, Cytokines, and Chemokines in Hispanic Women with HIV Cognitive Impairment
07:30 AM - 12:00 PM	Abstract	120 - Age Related HIV-Associated Neurocognitive Dysfunction
07:30 AM - 12:00 PM	Abstract	121 - Comparative Pathogenesis of the SAD-L16 Strain of Rabies Virus and a Mutant Modifying the Dynein Light Chain Binding Site in Young Mice
07:30 AM - 12:00 PM	Abstract	122 - TNF-alpha Leads to Increased Cell Surface Expression of CXCR4 in SK-N-MC Cells: Another Mechanism of Neuronal Injury in the HIV-Infected Brain
07:30 AM - 12:00 PM	Abstract	123 - Highly Active Antiretroviral Therapy in a SCID Mouse Model of HIV-Encephalitis Reduces Neuropathology and Viral Load
07:30 AM - 12:00 PM	Abstract	124 - Latency of HIV Infection in Astrocytes Is Regulated by Promyelocytic Leukemia Protein
07:30 AM - 12:00 PM	Abstract	125 - Detection of Spiroplasma DNA in TSE-Infected Brains and Sera
07:30 AM - 12:00 PM	Abstract	126 - A Prion Protein Missense Mutation in a Family with Early-Onset Dementia, Neuropsychiatric Disorders in Childhood and Adolescence, and Extrapyramidal Features
07:30 AM - 12:00 PM	Abstract	127 - The Function of Herpes Simplex Virus Type 1 Latency Associated Gene in the Transgenic Mouse Expressing This Gene
07:30 AM - 12:00 PM	Abstract	128 - The Use of Organotypic Brain Slices for the Study of Herpes Simplex Virus Type 1 Neurotropism
07:30 AM - 12:00 PM	Abstract	129 - Establishing the Prevalence of LGMD Genotypes in North America: An Ongoing Multi-Center Collaborative Study
07:30 AM - 12:00 PM	Abstract	130 - Clinical and Genetic Features of a Novel Autosomal Dominant Limb-Girdle Muscular Dystrophy 1F (LGMD 1F)
07:30 AM - 12:00 PM	Abstract	131 - A Peculiar Form of Limb Girdle Muscular Dystrophy with Combined Dysferlin and Calpain-3 Deficiency and Probable Autosomal Dominant Inheritance
07:30 AM - 12:00 PM	Abstract	132 - Uniformity in Clinical Features and Pattern of Progression in Autosomal Dominant Limb-Girdle Muscular Dytrophy with Cardiac Conduction Block (LGMD1B) in Four Cases from Two Large Japanese Families
07:30 AM - 12:00 PM	Abstract	133 - Titin M-Line Mutations: New Phenotypes besides Tibial Muscular Dystrophy and Severe LGMD2J
07:30 AM - 12:00 PM	Abstract	134 - Testing Stabilizing Function of Dystrophin in Human Duchenne Muscle Dystrophy Cells (DMD) vs. Control Cells (CC) Due to Lowered Stress Tolerance: Promising In Vitro Testing Tool for Possible Functional Vital Transfection Efficiency Measurements
07:30 AM - 12:00 PM	Abstract	135 - Missense Mutations in the Actin Binding Domain (ABD) of Dystrophin Cause Muscular Dystrophy by Disrupting Protein Stability
07:30 AM - 12:00 PM	Abstract	136 - Oculopharyngeal Muscular Dystrophy: An Uruguayan Population with 11 (GCG) Repeats
07:30 AM - 12:00 PM	Abstract	137 - Two Years Experience in the Diagnosis of Dysferlinopathies Using Dysferlin Expression in Monocytes
07:30 AM - 12:00 PM	Abstract	138 - Reduced Sialylation and Abnormal Glycosylation in Skeletal Muscles with Distal Myopathy with Rimmed Vacuoles
07:30 AM - 12:00 PM	Abstract	139 - Electrophysiologic Critieria Defining Charcot-Marie-Tooth Disease with Intermediate Conduction Velocities
07:30 AM - 12:00 PM	Abstract	140 - DI-CMTC: Dominant Intermediate Charcot-Marie-Tooth Disease Type C. A Neurophysiologic Study of 2 Families in Bulgaria and the USA
07:30 AM - 12:00 PM	Abstract	141 - Seven Novel Mutations and One Family with Both Cx32 and EGR2 Mutations on Genetic Analysis in the PMP22, MPZ, Cx32, EGR2, and NEFL Genes in CMT Patients
07:30 AM - 12:00 PM	Abstract	142 - A CMT1C Family with Gly112 Ser Mutation in LITAF/Simple: Mild Phenotype, Minimal Axonal Loss and Slow Conduction Velocities
07:30 AM - 12:00 PM	Abstract	143 - Exogenous Brain Derived and Ciliary Neurotrophic Factors in the Wildtype and Trembler-j Mouse, a Model for CMT1A
07:30 AM - 12:00 PM	Abstract	144 - Clinical, Pathological and Molecular Phenotype of a Human MPZ Mutation: An Autopsy Study
07:30 AM - 12:00 PM	Abstract	145 - The Proteolipid Protein-Specific Region of PLP Is Necessary for Normal Peripheral Nerve Function
07:30 AM - 12:00 PM	Abstract	146 - A Sensory and Motor Neuropathy with a Predominant Proprioceptive Ataxia
07:30 AM - 12:00 PM	Abstract	147 - SPTLC1 Mutation Analysis in Dominantly Inherited Sensory Neuropathies and Cryptogenic Sensory Neuropathy
07:30 AM - 12:00 PM	Abstract	148 - Is There Beta-Adrenergic Hypersensitivity in Patients with Postural Tachycardia Syndrome?
07:30 AM - 12:00 PM	Abstract	149 - Baroreflex Control of Muscle Sympathetic Nerve Activity in the Postural Orthostatic Tachycardia Syndrome
07:30 AM - 12:00 PM	Abstract	151 - Influence of Acetylcholinesterase Inhibition on Baroreflex Sensitivity in Patients with Orthostatic Intolerance
07:30 AM - 12:00 PM	Abstract	152 - Focal Disruption of the Blood Brain Barrier and False Cerebral Vasospasm in a Patient with Hypertensive Encephalopathy and Chronic Baroreflex Failure
07:30 AM - 12:00 PM	Abstract	153 - Midodrine Does Not Alter Dynamic Cerebral Autoregulation in Orthostatic Intolerance
07:30 AM - 12:00 PM	Abstract	154 - Sympathetic Noradrenergic and Baroreflex Failure in Parkinson Disease with Orthostatic Hypotension
07:30 AM - 12:00 PM	Abstract	155 - Episodic Collapse Unexpalined by Orthostatic Hypotension in a Case of Doapmine Beta Hydroxylase Deficiency
07:30 AM - 12:00 PM	Abstract	157 - Proximal Small Fiber Neuropathy - An Oxymoron or a Real Clinical Entity?
07:30 AM - 12:00 PM	Abstract	158 - 52-Week Prospective Randomized, Double-Blind Placebo-Controlled Safety and Efficacy Study of 2 Dosages of Botulinum Toxin Type-A Treatment for Primary Axillary Hyperhidrosis

Faculty Disclosures
Reza R. Zarnegar, DO	No disclosure on file
Jullie W. Pan, MD, PhD	No disclosure on file
Viktor Szeder, MD, PhD	Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Szeder has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Carroll, Kelly, Trotter, Franzen, McBride & Peabody LLP. Dr. Szeder has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Peabody and Buccini LLP.
	No disclosure on file
Paul B. Rizzoli, MD, F�鶹��ýӳ��	Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Axsome. Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Theranica. Dr. Rizzoli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Axsome. Dr. Rizzoli has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. Dr. Rizzoli has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Harvard Health Publishing. The institution of Dr. Rizzoli has received research support from Abbvie. Dr. Rizzoli has received publishing royalties from a publication relating to health care.
Argye E. Hillis, MD, MA	Dr. Hillis has received personal compensation for serving as an employee of Johns Hopkins University. Dr. Hillis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Heart Association. The institution of Dr. Hillis has received research support from NIH. Dr. Hillis has received publishing royalties from a publication relating to health care. Dr. Hillis has received personal compensation in the range of $500-$4,999 for serving as a NIDCD Council Member with NIH.
Volker A. Knappertz, MD	Dr. Knappertz has received personal compensation for serving as an employee of Noema Pharmaceuticals . Dr. Knappertz has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Sutura Pharmaceutical . Dr. Knappertz has received intellectual property interests from a discovery or technology relating to health care.
Aaron E. Miller, MD, F�鶹��ýӳ��	Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Accordant Health Services (Caremark). Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Corevitas (formerly known as Corrona). Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for MAPI=Pharma. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Viatris (Mylan). Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint Global. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Gerson Lehrman Group. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen Idec. Dr. Miller has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Miller has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amgen (Horizon Therapeutics). Dr. Miller has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Sterne Kessler. Dr. Miller has received publishing royalties from a publication relating to health care.
Michael S. Okun, MD, F�鶹��ýӳ��	Dr. Okun has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for NIH. Dr. Okun has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for Parkinson's Foundation. Dr. Okun has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for JAMA Neurology. Dr. Okun has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Journal Watch. The institution of Dr. Okun has received research support from NIH. The institution of Dr. Okun has received research support from Parkinson's Foundation. The institution of Dr. Okun has received research support from Tourette Association of America. The institution of Dr. Okun has received research support from Michael J Fox. Dr. Okun has received publishing royalties from a publication relating to health care.
Mustapha A. Ezzeddine, MD, F�鶹��ýӳ��	The institution of Dr. Ezzeddine has received research support from NIH.
William B. Young, MD, F�鶹��ýӳ��	Dr. Young has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Allergan. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biohaven Pharmaceuticals. Dr. Young has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Young has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biohaven Pharmaceuticals Inc. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Eli Lilly and Company. Dr. Young has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Teva. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Coalition for Headache and Migraine Patients. Dr. Young has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Miles for Migraine. The institution of Dr. Young has received research support from Amgen. The institution of Dr. Young has received research support from Cumberland. The institution of Dr. Young has received research support from Eli Lilly. The institution of Dr. Young has received research support from Novartis. The institution of Dr. Young has received research support from PCORI. The institution of Dr. Young has received research support from Satsuma. The institution of Dr. Young has received research support from Scion. The institution of Dr. Young has received research support from Teva. The institution of Dr. Young has received research support from Zosano.
Pramod K. Pal, MD, MBBS, DNB, DM	No disclosure on file
Suneel K. Gupta, PhD	No disclosure on file
Kathrin LaFaver, MD, F�鶹��ýӳ��	Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Teva. Dr. LaFaver has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acorda. Dr. LaFaver has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for WALL, WALL & FRAUENHOFER, LLP. The institution of Dr. LaFaver has received research support from Ayers Foundation. Dr. LaFaver has received publishing royalties from a publication relating to health care. Dr. LaFaver has a non-compensated relationship as a Board Member with FND Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. LaFaver has a non-compensated relationship as a Medical Advisor with FND Hope that is relevant to �鶹��ýӳ�� interests or activities.
Marcel Hungs, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Massimo Filippi, MD, F�鶹��ýӳ��	Dr. Filippi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion, Almirall, Biogen, Merck, Novartis, Roche, Sanofi. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion, Biogen, Bristol-Myers Squibb, Merck, Novartis, Roche, Sanofi, Sanofi-Aventis, Sanofi-Genzyme, Takeda. Dr. Filippi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer, Biogen, Celgene, Chiesi Italia SpA, Eli Lilly, Genzyme, Janssen, Merck-Serono, Neopharmed Gentili, Novartis, Novo Nordisk, Roche, Sanofi, Takeda, and TEVA. Dr. Filippi has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer Nature. The institution of Dr. Filippi has received research support from Biogen Idec, Merck-Serono, Novartis, Roche, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Andrea Falini	No disclosure on file
Nir Giladi, MD, F�鶹��ýӳ��	Dr. Giladi has received personal compensation in the range of $0-$499 for serving as a Consultant for Sionara. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NeuroDerm. Dr. Giladi has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pharma2B. Dr. Giladi has stock in Vibrant. Dr. Giladi has stock in Lysosomal Therapeutics . The institution of Dr. Giladi has received research support from The Michael J Fox Foundation. The institution of Dr. Giladi has received research support from The National Parkinson Foundation. The institution of Dr. Giladi has received research support from The European Union . The institution of Dr. Giladi has received research support from The Israel Science Foundation. The institution of Dr. Giladi has received research support from Biogen . The institution of Dr. Giladi has received research support from Ionis. The institution of Dr. Giladi has received research support from Sieratzki Family Foundation . The institution of Dr. Giladi has received research support from The Aufzien Academic Center in Tel-Aviv University.
David L. Tirschwell, MD, F�鶹��ýӳ��	Dr. Tirschwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Boston Scientific. The institution of Dr. Tirschwell has received research support from Abbott. The institution of Dr. Tirschwell has received research support from NIH.
Omar A. Khan, MD, PhD	No disclosure on file
Daniel Reich, MD, PhD	Dr. Reich has received research support from NIH. The institution of Dr. Reich has received research support from Adelson Medical Research Foundation. The institution of Dr. Reich has received research support from Sanofi. The institution of Dr. Reich has received research support from Abata Therapeutics. The institution of Dr. Reich has received research support from National Multiple Sclerosis Society. The institution of Dr. Reich has received research support from Cure Alzheimer's Fund. Dr. Reich has received intellectual property interests from a discovery or technology relating to health care. Dr. Reich has received personal compensation in the range of $5,000-$9,999 for serving as a CME Faculty with Integrity. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Letters and Sciences. Dr. Reich has received personal compensation in the range of $500-$4,999 for serving as a CME Faculty with Academic CME. Dr. Reich has a non-compensated relationship as a Advisor with Sanofi that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Board of Directors with ACTRIMS that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Abata Therapeutics that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with University of Basel RC2NB that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Multiple Sclerosis Society of Canada that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Tuscan Doctorate in Neuroscience that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Editorial Board with Multiple Sclerosis Journal that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Hyperfine that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Imaginab that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Annexon that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator, Advisor with Philips that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Siemens that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Calico Life Sciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Cognito Therapeutics that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Sudo that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with Allumis that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with BioCentury that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Regeneron that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Collaborator with Eli Lilly that is relevant to �鶹��ýӳ�� interests or activities. Dr. Reich has a non-compensated relationship as a Advisor with SetPoint that is relevant to �鶹��ýӳ�� interests or activities.
Kelly D. Foote, MD	Kelly D. Foote, MD has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Axio/Neurocrine Biosciences.
Gavin Giovannoni, MD	Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck KGaA. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche-Genentech. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Moderna. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sandoz. Dr. Giovannoni has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Astoria Biologica. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Giovannoni has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Giovannoni has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Medscape.
Hiroyuki Ishiura, MD	No disclosure on file
Alan R. Hirsch, MD, FACP	Dr. Hirsch has nothing to disclose.
Mitzi J. Williams, MD, F�鶹��ýӳ��	Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen Idec. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis Pharmaceuticals. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Williams has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Genentech. Dr. Williams has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi. Dr. Williams has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has received publishing royalties from a publication relating to health care. Dr. Williams has a non-compensated relationship as a National Board Member with National MS Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Williams has a non-compensated relationship as a Board Trustee with Consortium of MS Centers that is relevant to �鶹��ýӳ�� interests or activities. Dr. Williams has a non-compensated relationship as a Board Chair with Joi Life Foundation that is relevant to �鶹��ýӳ�� interests or activities.
Mario F. Mendez, MD, PhD, F�鶹��ýӳ��	Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medical �鶹��ýӳ�� Speakers' Bureau. Dr. Mendez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for UpToDate. The institution of Dr. Mendez has received research support from NIH. Dr. Mendez has received publishing royalties from a publication relating to health care.
Daniel Pelletier, MD	Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Pelletier has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Pelletier has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Pelletier has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Polpharma Biologics.
Naim I. Haddad, MD, F�鶹��ýӳ��	Dr. Haddad has nothing to disclose.
Micheline B. McCarthy, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Sherron H. Kell, MD	No disclosure on file
Charlene Gamaldo, MD, F�鶹��ýӳ��	Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for johns hopkins. Dr. Gamaldo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Jazz. Dr. Gamaldo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Gamaldo has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Apnimed. The institution of Dr. Gamaldo has received research support from NIH/NIMH/NIDA/NINDS. Dr. Gamaldo has received publishing royalties from a publication relating to health care.
Lisa M. DeAngelis, MD, F�鶹��ýӳ��	Dr. DeAngelis has received publishing royalties from a publication relating to health care.
Jeremy D. Schmahmann, MD, F�鶹��ýӳ��	Dr. Schmahmann has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biohaven. The institution of Dr. Schmahmann has received research support from National Ataxia Foundation. The institution of Dr. Schmahmann has received research support from Biohaven. Dr. Schmahmann has received intellectual property interests from a discovery or technology relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care. Dr. Schmahmann has received publishing royalties from a publication relating to health care.
Diana Castro, MD	Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for PTC. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Castro has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. The institution of Dr. Castro has received research support from Biogen. The institution of Dr. Castro has received research support from Sarepta. The institution of Dr. Castro has received research support from Fibrogen .
Elena Bravver, MD	No disclosure on file
Gilles Allali, MD, PhD	Dr. Allali has nothing to disclose.
Michelle Cameron, MD	Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Greenwich Biosciences/Jazz . Dr. Cameron has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Adamas Pharmaceuticals. Dr. Cameron has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Cameron has received research support from National MS Society. The institution of Dr. Cameron has received research support from Department of Veterans Affairs. Dr. Cameron has received publishing royalties from a publication relating to health care.
Claudio Gasperini, MD	Dr. Gasperini has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche, Merck, Genzyme, Novartis,Bayer, Teva, Almirall.
Hans-Peter Hartung, MD, F�鶹��ýӳ��	Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS Celgene. Dr. Hartung has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Geneuro. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Hartung has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Hartung has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers Neurology.
Filippo Martinelli Boneschi	No disclosure on file
Robert A. Hauser, MD, MBA, F�鶹��ýӳ��	Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Supernus. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoparkinson. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Revance. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Abbvie. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurocrine. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amneal. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Intrance. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zambon. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for NanoPharmasolutions. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for HanAll BioPharma. Dr. Hauser has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Cerevance. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Clario. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sumitomo. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Taurus Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sorriddi Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Contera. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Lundbeck. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alterity Therapeutics. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Convatec Inc. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Knight Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Acadia. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biorasi. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medicure Pharma. Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BlueRock. Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inhibikase. The institution of Dr. Hauser has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stoparkinson. The institution of Dr. Hauser has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Photopharmics. The institution of Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for ABLi Therapeutics. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Amneal . Dr. Hauser has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Neurocrine Biosciences. Dr. Hauser has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Supernus. Dr. Hauser has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Hauser has or had stock in Inhibikase.Dr. Hauser has or had stock in Axial Therapeutics.Dr. Hauser has or had stock in Enterin.Dr. Hauser has or had stock in Photopharmics. The institution of Dr. Hauser has received research support from Annovis Bio, Inc.. The institution of Dr. Hauser has received research support from Inhibikase Therapeutics. The institution of Dr. Hauser has received research support from AbbVie, Inc.. The institution of Dr. Hauser has received research support from Biogen MA. The institution of Dr. Hauser has received research support from Cavion, Inc.. The institution of Dr. Hauser has received research support from Cerevance Beta, Inc.. The institution of Dr. Hauser has received research support from Cerevel Therapeutics. The institution of Dr. Hauser has received research support from Enterin, Inc.. The institution of Dr. Hauser has received research support from Genentech. The institution of Dr. Hauser has received research support from Global Kinetics Corporation. The institution of Dr. Hauser has received research support from Hoffman-La Roche Inc. The institution of Dr. Hauser has received research support from Michael J. Fox Foundation for Parkinson's Research. The institution of Dr. Hauser has received research support from National Parkinson's Foundation. The institution of Dr. Hauser has received research support from Neuroderm. The institution of Dr. Hauser has received research support from Sage Therapeutics. The institution of Dr. Hauser has received research support from Scion NeuroStim. The institution of Dr. Hauser has received research support from UCB BioPharma. The institution of Dr. Hauser has received research support from UCB. The institution of Dr. Hauser has received research support from Amneal Pharmaceuticals. The institution of Dr. Hauser has received research support from Motric Bio, Inc.. The institution of Dr. Hauser has received research support from Sun Pharma Advanced Research Company. The institution of Dr. Hauser has received research support from Teva Branded Pharmaceuticals. The institution of Dr. Hauser has received research support from Truebinding, Inc.. The institution of Dr. Hauser has received research support from Jazz Pharmaceuticals. The institution of Dr. Hauser has received research support from Ipsen. Dr. Hauser has received intellectual property interests from a discovery or technology relating to health care.
Mark Stacy, MD	Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biovie. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for National Institute of Aging. Dr. Stacy has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Dartmouth. Dr. Stacy has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal.
Stacey Clardy, MD, PhD, F�鶹��ýӳ��	Dr. Clardy has received personal compensation for serving as an employee of Veterans Health Administration (VHA). Dr. Clardy has received personal compensation for serving as an employee of University of Utah Health. Dr. Clardy has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AstraZeneca/Alexion. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen/Horizon. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Arialys. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. Dr. Clardy has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology/�鶹��ýӳ�� Publications. The institution of Dr. Clardy has received research support from NIH/NINDS. The institution of Dr. Clardy has received research support from SRNA. The institution of Dr. Clardy has received research support from Alexion/AstraZeneca. The institution of Dr. Clardy has received research support from Kyverna. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a �鶹��ýӳ�� Summer Meeting CoDirector Travel and Lodging with �鶹��ýӳ��. Dr. Clardy has received personal compensation in the range of $500-$4,999 for serving as a Grand Rounds Travel/Lodging/Honoraria with U of Iowa, Miami, Stanford, Barrow, Advent Health Florida, Beaumont Health, CCF, Emory, Penn State Health, Mayo Clinic, Walter Reed.
Bryan Traynor, MD	The institution of Dr. Traynor has received research support from ALS Association. The institution of Dr. Traynor has received research support from Merck. The institution of Dr. Traynor has received research support from Myasthenia Gravis Foundation. The institution of Dr. Traynor has received research support from Cerevel Therapeutics. Dr. Traynor has received intellectual property interests from a discovery or technology relating to health care.
Nicolas Dupre, MD, F�鶹��ýӳ��	Dr. Dupre has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Akcea Therapeutics Canada. The institution of Dr. Dupre has received research support from ARSACS Foundation. The institution of Dr. Dupre has received research support from CHUdeQuebec Foundation.
Paul G. Mathew, MD, DNBPAS, FAHS, FACSM, F�鶹��ýӳ��	Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie/Allergan. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Lilly. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Mathew has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biohaven/Pfizer. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Theranica. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Impel. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Upsher Smith. Dr. Mathew has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Linpharma. Dr. Mathew has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbvie.
Alan Lerner, MD	The institution of Dr. Lerner has received research support from Premier applied biosciences. Dr. Lerner has received publishing royalties from a publication relating to health care.
Edgar J. Kenton III, MD	No disclosure on file
Bahareh Hassanzadeh, MD	Dr. Hassanzadeh has nothing to disclose.
Tjalf Ziemssen, MD, F�鶹��ýӳ��	Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS . Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Dr. Ziemssen has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Dr. Ziemssen has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Dresden Internation University. The institution of Dr. Ziemssen has received research support from Novartis. The institution of Dr. Ziemssen has received research support from Merck. The institution of Dr. Ziemssen has received research support from Sanofi. The institution of Dr. Ziemssen has received research support from BMS. The institution of Dr. Ziemssen has received research support from Roche.
Nicte Mejia, MD, MPH, F�鶹��ýӳ��	Dr. Mejia has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Mejia has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology. The institution of Dr. Mejia has received research support from Biogen Foundation.
Arun R. Antony, MD	Dr. Antony has nothing to disclose.
Sudha Seshadri, MD, F�鶹��ýӳ��	Dr. Seshadri has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novo Nordisk. The institution of Dr. Seshadri has received research support from NIH. The institution of Dr. Seshadri has received research support from Alzheimer Association.
Jeffrey L. Saver, MD, F�鶹��ýӳ��	Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stryker. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cerenovus. Dr. Saver has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim (prevention only). Dr. Saver has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Medical Association. Dr. Saver has received stock or an ownership interest from Rapid Medical.
William O. Tatum IV, DO, F�鶹��ýӳ��	Dr. Tatum has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Bioserenity. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Natus. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Neurelis. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Elsevier. Dr. Tatum has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Defense Law Firm on behalf of a patient with epilepsy with funds donated to the Epilepsy Foundation of America. The institution of Dr. Tatum has received research support from Esai. The institution of Dr. Tatum has received research support from Mayo Clinic. The institution of Dr. Tatum has received research support from Liva Nova. The institution of Dr. Tatum has received research support from Engage Pharmaceuticals. The institution of Dr. Tatum has received research support from Xenon. Dr. Tatum has received intellectual property interests from a discovery or technology relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has received publishing royalties from a publication relating to health care. Dr. Tatum has a non-compensated relationship as a �鶹��ýӳ�� Section Chair of Clinical Neurophysiology with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities.
Matthew Rizzo, MD, F�鶹��ýӳ��	The institution of Dr. Rizzo has received research support from NIH.
Bassel W. Abou-Khalil, MD, F�鶹��ýӳ��	The institution of Dr. Abou-Khalil has received research support from Cerevel. The institution of Dr. Abou-Khalil has received research support from Xenon. The institution of Dr. Abou-Khalil has received research support from Otsuka. The institution of Dr. Abou-Khalil has received research support from UCB. The institution of Dr. Abou-Khalil has received research support from SK LIfe Science. The institution of Dr. Abou-Khalil has received research support from Neuroelectrics.
Tahseen Mozaffar, MD, F�鶹��ýӳ��	Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Amicus. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Grifols. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Astellas Gene Therapy. Dr. Mozaffar has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bayer. Dr. Mozaffar has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Applied Therapeutics. The institution of Dr. Mozaffar has received research support from NIH. The institution of Dr. Mozaffar has received research support from Muscular Dystrophy Association. The institution of Dr. Mozaffar has received research support from Sanofi. The institution of Dr. Mozaffar has received research support from Argenx. The institution of Dr. Mozaffar has received research support from Amicus Therapeutics. The institution of Dr. Mozaffar has received research support from Astellas Gene Therpay. The institution of Dr. Mozaffar has received research support from Cartesian. The institution of Dr. Mozaffar has received research support from Cabaletta. Dr. Mozaffar has received personal compensation in the range of $500-$4,999 for serving as a Study Section Member with NIH.
Aaron L. Boster, MD	Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for sanofi. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for roche. Dr. Boster has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for novartis. Dr. Boster has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Boster has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Serono. The institution of Dr. Boster has received research support from Sanofi. The institution of Dr. Boster has received research support from Roche.
Jaime R. Lopez, MD	An immediate family member of Dr. Lopez has received personal compensation for serving as an employee of AbbVie. Dr. Lopez has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Lopez has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for medical-legal consulting.
Deanna Saylor, MD, MHS, F�鶹��ýӳ��	Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from �鶹��ýӳ��. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to �鶹��ýӳ�� interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and �鶹��ýӳ��al Innovation Commitees with American Neurological Association that is relevant to �鶹��ýӳ�� interests or activities.
Regina Berkovich, MD, PhD	The institution of Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Alexion, Biogen, Genentec, Mallincrodt, Sanofi, Novartis, . Dr. Berkovich has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen, Genentec, Sanofi, Merck . Dr. Berkovich has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Alexion, Biogen, Sanofi, Merck, Mallincrodt . The institution of Dr. Berkovich has received research support from Biogen, Sanofi, Merck.
Anna D. Hohler, MD, F�鶹��ýӳ��	Dr. Hohler has nothing to disclose.
Maria P. Amato, PhD	Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation for serving as an employee of AOU Careggi. Dr. Amato has received personal compensation for serving as an employee of AOUCareggi. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi Genzyme. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi genzyme. The institution of Dr. Amato has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene BMS. The institution of Dr. Amato has received research support from Merck. The institution of Dr. Amato has received research support from Biogen. The institution of Dr. Amato has received research support from Roche.
Angelo Ghezzi, MD	No disclosure on file
Irene Malaty, MD, F�鶹��ýӳ��	Dr. Malaty has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Aevum. The institution of Dr. Malaty has received research support from Abbvie. The institution of Dr. Malaty has received research support from Revance. The institution of Dr. Malaty has received research support from Parkinson Foundation. The institution of Dr. Malaty has received research support from SAGE. The institution of Dr. Malaty has received research support from Emalex. The institution of Dr. Malaty has received research support from Acadia. Dr. Malaty has received publishing royalties from a publication relating to health care. Dr. Malaty has received personal compensation in the range of $500-$4,999 for serving as a Speaker & Center of Excellence Director with Parkinson Foundation. Dr. Malaty has a non-compensated relationship as a MAB member & Center of Excellence Directory with Tourette Association of America that is relevant to �鶹��ýӳ�� interests or activities.
Thomas J. Kaley, MD	Dr. Kaley has received publishing royalties from a publication relating to health care.
Edward Fox, MD, PhD, F�鶹��ýӳ��	Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GW Pharmaceuticals. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG Therapeutics. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Fox has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Fox has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Alexion. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Fox has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. The institution of Dr. Fox has received research support from Biogen. The institution of Dr. Fox has received research support from Genentech. The institution of Dr. Fox has received research support from Celgene - BMS. The institution of Dr. Fox has received research support from Chugai. The institution of Dr. Fox has received research support from Novartis. The institution of Dr. Fox has received research support from EMD-Serono. The institution of Dr. Fox has received research support from TG Therapeutics. The institution of Dr. Fox has received research support from AbbVie. The institution of Dr. Fox has received research support from Sanofi Genzyme. The institution of Dr. Fox has received research support from AbbVie.
Nicholas J. Maragakis, MD, F�鶹��ýӳ��	Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UptoDate. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Apellis Pharmaceuticals. Dr. Maragakis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. An immediate family member of Dr. Maragakis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for National Basketball Association. Dr. Maragakis has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Akava. An immediate family member of Dr. Maragakis has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Johns Hopkins Howard County Medical Center. Dr. Maragakis has stock in Akava. The institution of Dr. Maragakis has received research support from NIH/NINDS. The institution of Dr. Maragakis has received research support from Department of Defense. The institution of Dr. Maragakis has received research support from Maryland Stem Cell Research Fund. Dr. Maragakis has received intellectual property interests from a discovery or technology relating to health care.
Elizabeth Finger, MD, F�鶹��ýӳ��	Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vigil Neuro. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Denali Therapeutics. The institution of Dr. Finger has received research support from CIHR. The institution of Dr. Finger has received research support from Physician Servcices Incorporated. The institution of Dr. Finger has received research support from Weston Foundation. Dr. Finger has received personal compensation in the range of $500-$4,999 for serving as a Annual Meeting Course Director with �鶹��ýӳ��.
David B. Burkholder, MD, F�鶹��ýӳ��	The institution of Dr. Burkholder has received research support from Longboard pharmaceuticals.
Peter J. Koudstaal, MD	No disclosure on file
M. M. Mesulam, MD, F�鶹��ýӳ��	Dr. Mesulam has received publishing royalties from a publication relating to health care.
Yasuo Iwasaki, MD	No disclosure on file
Maryann Mays, MD, F�鶹��ýӳ��	Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Pfizer. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Oakley Health. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CoolTech Medical. Dr. Mays has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Mays has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. The institution of Dr. Mays has received research support from Amgen. The institution of Dr. Mays has received research support from Lundbeck.
Pamela Rist, PhD	The institution of Dr. Rist has received research support from National Institutes of Health. The institution of Dr. Rist has received research support from Brigham and Women's Hospital. The institution of Dr. Rist has received research support from American Heart Association. The institution of Dr. Rist has received research support from Mars Edge.
Brij M. Ahluwalia-Singh, MD, F�鶹��ýӳ��	No disclosure on file
Steven W. Anderson, PhD	Dr. Anderson has nothing to disclose.
Irene Cortese, MD	Dr. Cortese has stock in Keires, AG. Dr. Cortese has stock in Nouscom, AG. Dr. Cortese has stock in PDC*line Pharma.
Daniel Kantor, MD, F�鶹��ýӳ��	Dr. Kantor has received personal compensation for serving as an employee of Gateway Institute for Brain Research. Dr. Kantor has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Kantor has a non-compensated relationship as a HAP with MSFous (MSF) that is relevant to �鶹��ýӳ�� interests or activities. Dr. Kantor has a non-compensated relationship as a Medical Board with MS Views & News that is relevant to �鶹��ýӳ�� interests or activities.
Sean J. Pittock, MD, F�鶹��ýӳ��	Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Pittock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. The institution of Dr. Pittock has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. The institution of Dr. Pittock has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion/AstraZeneka. The institution of Dr. Pittock has received research support from NIH. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received intellectual property interests from a discovery or technology relating to health care. Dr. Pittock has received publishing royalties from a publication relating to health care.
Haitham Hussein, MD, F�鶹��ýӳ��	Dr. Hussein has nothing to disclose.
Nathalie Jette, MD, MSc, FRCPC, F�鶹��ýӳ��	Dr. Jette has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for ILAE Epilepsia. The institution of Dr. Jette has received research support from NIH. The institution of Dr. Jette has received research support from AES.
Steven Vernino, MD, PhD, F�鶹��ýӳ��	Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for lundbeck. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Regeneron. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for argenx. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alterity. Dr. Vernino has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Autonomic Neuroscience (Elsevier). The institution of Dr. Vernino has received research support from Takeda. The institution of Dr. Vernino has received research support from NIH/NHLBI. The institution of Dr. Vernino has received research support from Lundbeck. The institution of Dr. Vernino has received research support from Regeneron.
Richard M. Dubinsky, MD, MPH, F�鶹��ýӳ��	Dr. Dubinsky has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Abbvie Pharmaceuticals. An immediate family member of Dr. Dubinsky has stock in Abbvie and Abbott Labs. The institution of Dr. Dubinsky has received research support from CHDI. The institution of Dr. Dubinsky has received research support from Prilenia. The institution of Dr. Dubinsky has received research support from Sage Pharmaceuticals. The institution of Dr. Dubinsky has received research support from NIH/NINDS. Dr. Dubinsky has a non-compensated relationship as a Member, independent data safety monitoring board with Roche that is relevant to �鶹��ýӳ�� interests or activities.
Nestor R. Gonzalez, MD	Nestor R. Gonzalez, MD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. The institution of Nestor R. Gonzalez, MD has received research support from National Institutes of Health. The institution of Nestor R. Gonzalez, MD has received research support from American Heart Associaton.
Karl Krecke	Karl Krecke has nothing to disclose.
Sidney Starkman, MD, F�鶹��ýӳ��	No disclosure on file
Latisha Sharma, MD	Dr. Sharma has nothing to disclose.
Laura De Giglio	No disclosure on file
Benjamin R. Brooks, MD, F�鶹��ýӳ��	Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Mitsubishi Tanabe Pharma America. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Medicinova. Dr. Brooks has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AB Science. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis. Dr. Brooks has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Mitsubishi Tanabe Pharma America. The institution of Dr. Brooks has received research support from Mitsubishi TanabePharma America. Dr. Brooks has received personal compensation in the range of $0-$499 for serving as a Member Annual Surveillance Committee CDC National ALS Registry with Center for Disease Control Agency Toxic Substances Disease Registry. Dr. Brooks has a non-compensated relationship as a Member ALS Quality Measures Subcommittee with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities.
R E. Faught, Jr., MD, F�鶹��ýӳ��	Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Neurelis. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for SK Life Science. Dr. Faught has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Gideon, Essary, Tardio and Carter PLC, Nashville TN TN law firm. Dr. Faught has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Friedman Dazio and Zulanas Law Firm Birmingham AL. The institution of Dr. Faught has received research support from UCB Pharma. The institution of Dr. Faught has received research support from Cognizance.
Christopher J. Boes, MD, F�鶹��ýӳ��	Dr. Boes has a non-compensated relationship as a Review Committee for Neurology member with ACGME that is relevant to �鶹��ýӳ�� interests or activities.
Kathleen M. Shannon, MD, F�鶹��ýӳ��	The institution of Dr. Shannon has received research support from Inhibikase Therapeutics. The institution of Dr. Shannon has received research support from ASKBIO. Dr. Shannon has received personal compensation in the range of $500-$4,999 for serving as a Grant reviewer with NIH.
Joan M. Ohayon	Joan M. Ohayon has nothing to disclose.
Alison M. Pack, MD, F�鶹��ýӳ��	An immediate family member of Dr. Pack has received personal compensation for serving as an employee of REGENEXBIO. The institution of Dr. Pack has received research support from National Institutes of Health. Dr. Pack has received publishing royalties from a publication relating to health care.
Maria A. Rocca	Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen, Bristol Myers Squibb, Eli Lilly, Janssen, Roche. Maria Assunta Rocca has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AstraZaneca, Biogen, Bristol Myers Squibb, Bromatech, Celgene, Genzyme, Horizon Therapeutics Italy, Merck Serono SpA, Novartis, Roche, Sanofi and Teva. The institution of Maria Assunta Rocca has received research support from MS Society of Canada, the Italian Ministry of Health, the Italian Ministry of University and Research, and Fondazione Italiana Sclerosi Multipla.
Saud Sadiq, BS, F�鶹��ýӳ��	Ms. Brewi has nothing to disclose.
Vladimir Hachinski, MD, DSc, F�鶹��ýӳ��	Dr. Hachinski has nothing to disclose.
Amir M. Arain, MD, F�鶹��ýӳ��	Dr. Arain has nothing to disclose.
Volker Limmroth, MD, PhD	No disclosure on file
Elisabetta Pagani	Elisabetta Pagani has nothing to disclose.
Rosana H. Scola, MD	Dr. Scola has nothing to disclose.
David Skoloudik, MD, PhD	No disclosure on file
Jeffrey Dawson	Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for iotaMotion. Jeffrey Dawson has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Congress of Neurological Surgeons. The institution of Jeffrey Dawson has received research support from Department of Veterans Affairs. The institution of Jeffrey Dawson has received research support from NIH.
Andrea N. Leep Hunderfund, MD	The institution of Dr. Leep Hunderfund has received research support from American Medical Association. The institution of Dr. Leep Hunderfund has received research support from Kern National Network for Caring and Character in Medicine. Dr. Leep Hunderfund has received intellectual property interests from a discovery or technology relating to health care.
Xavier Montalban, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck/ EMD Serono. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Teva. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Hoffmann-La Roche. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for BMS/ Celgene. The institution of Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi/ Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BIAL PD. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVoice. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung Biosys. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Zenas BioPharma. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion/ Janssen Pharmaceuticals. Dr. Montalban has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS/ Celgene. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck/ EMD Serono. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Hoffmann-La Roche. Dr. Montalban has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Immunic Therapeutics. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Viatris/ Mylan. The institution of Dr. Montalban has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. The institution of Dr. Montalban has received research support from Biogen. The institution of Dr. Montalban has received research support from Hoffmann-La Roche. The institution of Dr. Montalban has received research support from Sanofi/ Genzyme. The institution of Dr. Montalban has received research support from Merck/ EMD Serono. The institution of Dr. Montalban has received research support from Novartis. The institution of Dr. Montalban has received research support from Teva Pharmaceuticals. The institution of Dr. Montalban has received research support from Actelion/ Janssen Pharmaceuticals. The institution of Dr. Montalban has received research support from BMS/ Celgene.
Alexandra Urban, MD, F�鶹��ýӳ��	Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for Neuropace. Dr. Urban has received personal compensation in the range of $0-$499 for serving as a Consultant for LivaNova.
Emmanuel O. Sanya, MD	No disclosure on file
Kolawole W. Wahab, MD, F�鶹��ýӳ��	Dr. Wahab has nothing to disclose.
Eva Feldman, MD, PhD, F�鶹��ýӳ��	The institution of Dr. Feldman has received research support from National Institutes of Health. The institution of Dr. Feldman has received research support from Centers for Disease Control and Prevention / Agency for Toxic Substances and Disease Registry. The institution of Dr. Feldman has received research support from Juvenile Diabetes Research Foundation. Dr. Feldman has received intellectual property interests from a discovery or technology relating to health care. Dr. Feldman has a non-compensated relationship as a Editorial Board Member with Journal of the Peripheral Nervous System, Experimental Neurology, Nature Neurology Reviews, Neurobiology of Disease, NeuroRx, Journal of Neurology Neurosurgery and Psychiatry, Scientific Reports, Lancet Neurology, Med (Cell Press Journal) that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Editor-in-Chief with Oxford University Press Contemporary Neurology Series that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, and Chair of Section 07 with National Academy of Medicine that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Associate Editor with Annals of Neurology that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Governance Committee Chair with American Neurological Association that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Membership Committee Member, Strategic Planning Committee Member, Chair of Section 07, Neuroscience Forum, Council Member with National Academy of Medicine that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Committee on Making ALS a Livable Disease Member with National Academy of Sciences, Engineering, and Medicine that is relevant to �鶹��ýӳ�� interests or activities. Dr. Feldman has a non-compensated relationship as a Member, Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) External Oversight Committee with National Institutes of Health that is relevant to �鶹��ýӳ�� interests or activities.
Gena R. Ghearing, MD	The institution of Dr. Ghearing has received research support from Center for Disease Control and Prevention.
Elizabeth Loder, MD, MPH	Dr. Loder has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Loder has received personal compensation in the range of $100,000-$499,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for The BMJ.
Soma S. Ray	Soma S. Ray has received personal compensation for serving as an employee of Dyne Therapeutics. Soma S. Ray has stock in Dyne Therapeutics.
Mark S. Freedman, MD, F�鶹��ýӳ��	Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Actelion(Janssen/J&J). Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BiogenIdec. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS/Celgene. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Inc. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Actelion (Janssen/J&J). Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Atara Biotherapeutics. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Bayer Healthcare. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for BiogenIdec. Dr. Freedman has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Clene Nanomedicine. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GRI Bio. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Magenta Therapeutics. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Freedman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Freedman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme. Dr. Freedman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for EMD Serono. The institution of Dr. Freedman has received research support from Sanofi Genzyme.
Alexa Beiser	Alexa Beiser has nothing to disclose.
Giancarlo Comi, MD	Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Janssen. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Aspen Healthcare. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sanofi. Dr. Comi has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Rewind.
Nimish A. Mohile, MD, F�鶹��ýӳ��	The institution of Dr. Mohile has received research support from Novocure.
Jiwon Oh, MD, F�鶹��ýӳ��	Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche. The institution of Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen-Idec. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD-Serono. Dr. Oh has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi-Genzyme. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Oh has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen-Idec. Dr. Oh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi-Genzyme. The institution of Dr. Oh has received research support from Biogen-Idec. The institution of Dr. Oh has received research support from Roche.
Douglas L. Arnold, MD, F�鶹��ýӳ��	Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for BMS. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Frequency Therapeutics. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Novartis. Dr. Arnold has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Arnold has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Shionogi. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Xfacto communications. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Find therapeutics. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Idorsia. Dr. Arnold has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Kiniksa. Dr. Arnold has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Clario.
Muna Irfan, MD	Dr. Irfan has nothing to disclose.
Lucia Moiola, MD, PhD	Dr. Moiola has nothing to disclose.
Vittorio Martinelli	Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis, Biogen, Sanofi Genzyme, TEVA and Merck. Dr. Martinelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck .
Keith R. Edwards, MD, F�鶹��ýӳ��	No disclosure on file
John E. Greenlee, MD, F�鶹��ýӳ��	Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Medlink. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Zeigler Cohen Roche. Dr. Greenlee has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Sommers Schwartz PC. Dr. Greenlee has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for St Francis Hospital. Dr. Greenlee has received publishing royalties from a publication relating to health care. Dr. Greenlee has received publishing royalties from a publication relating to health care.
Richard A. Lewis, MD, F�鶹��ýӳ��	Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL Behring. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Grifols. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Nuvig. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Dianthus. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medscape. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioCryst. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NervoSave. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Annexon. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TGTX. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Boehringer-Ingleheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Cartesian. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CME Outfitters. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PeerVision. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Up to Date. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Boehringer Ingelheim. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alnylam. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Intellia. Dr. Lewis has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Shernoff et al. Dr. Lewis has received publishing royalties from a publication relating to health care.
Evan Y. Snyder, MD, PhD	No disclosure on file
Carolyn M. Sue, MBBS, PhD, FRACP	No disclosure on file
Tamar Bacon	The institution of an immediate family member of Tamar Bacon has received research support from Novartis. The institution of an immediate family member of Tamar Bacon has received research support from Genentech. An immediate family member of Tamar Bacon has received publishing royalties from a publication relating to health care.
Jorge C. Kattah, MD, F�鶹��ýӳ��	Dr. Kattah has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Bonezzi, Switzer , Poilitto and Hupp Legal Firm.
Daniel L. Labovitz, MD	An immediate family member of Dr. Labovitz has received personal compensation for serving as an employee of Herrick Feinstein.
David S. Liebeskind, MD, F�鶹��ýӳ��	Dr. Liebeskind has received research support from Cerenovus. Dr. Liebeskind has received research support from Genentech . Dr. Liebeskind has received research support from Medtronic. Dr. Liebeskind has received research support from Stryker.
Hugh Kearney, MD, PhD	Dr. Kearney has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen.
Ergun Y. Uc, MD	An immediate family member of Dr. Uc has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for American Board of Pediatrics. The institution of Dr. Uc has received research support from Department of Veterans Affairs. The institution of Dr. Uc has received research support from Department of Defense. The institution of an immediate family member of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from NIH. The institution of Dr. Uc has received research support from Parkinson's Foundation. The institution of Dr. Uc has received research support from NIH.
Bruno Colombo	Bruno Colombo has nothing to disclose.
Gianna Carla Riccitelli	No disclosure on file
Paola Valsasina	Paola Valsasina has nothing to disclose.
Marilou I. Ching, MD	Dr. Ching has nothing to disclose.
Christopher Goetz, MD, F�鶹��ýӳ��	The institution of Dr. Goetz has received research support from Michael J. Fox Foundation. The institution of Dr. Goetz has received research support from NIH. The institution of Dr. Goetz has received research support from Department of Defense. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care. Dr. Goetz has received publishing royalties from a publication relating to health care.
Vesna V. Brinar, MD, PhD	No disclosure on file
Violaine K. Harris, PhD	No disclosure on file
Ken Ikeda, MD, PhD	No disclosure on file
Peter J. Koehler, MD, PhD, F�鶹��ýӳ��	Dr. Koehler has nothing to disclose.
Tobias Kurth, MD, ScD, F�鶹��ýӳ��	Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for TotalEnergies. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eli Lilly & Company. Dr. Kurth has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for BMJ. Dr. Kurth has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Frontiers. The institution of Dr. Kurth has received research support from German Joint Committee. The institution of Dr. Kurth has received research support from Ministry of Health.
Jonathan S. Katz, MD	Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Calico. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for CSL Behring. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Denali. Dr. Katz has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Griffols. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Katz has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Joyce A. Cramer	No disclosure on file
Andrew H. Evans, MB, BS	Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Stada. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Ipsen. Mr. Evans has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for AbbVie. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Stada. The institution of Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Ipsen. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Seqirus. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bluerock. Mr. Evans has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Encapsulate.
Ralf Linker	Dr. Linker has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Linker has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Springer. The institution of Dr. Linker has received research support from Novartis. The institution of Dr. Linker has received research support from Biogen.
Shoji Tsuji, MD, PhD	The institution of Dr. Tsuji has received research support from Novelpharma Co. Ltd..
Jerry S. Wolinsky, MD, F�鶹��ýӳ��	Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Avotres. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Brainstorm Cell Therapeutics. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cleveland Clinic Foundation. Dr. Wolinsky has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Inmagene. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis/Sandoz. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wolinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for University of Alabama Birmingham. Dr. Wolinsky has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Wolinsky has received intellectual property interests from a discovery or technology relating to health care.
Michal Kral	No disclosure on file
Christopher C. LaGanke, MD	Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Sanofi. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Novartis. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for GSK. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Serono EMD. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. LaGanke has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. LaGanke has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Viet Nguyen, MD	Dr. Nguyen has received personal compensation for serving as an employee of Biogen. Dr. Nguyen has stock in Biogen.
Cynthia L. Harden, MD	Dr. Harden has received personal compensation for serving as an employee of Xenon Pharmaceuticals Inc.. Dr. Harden has stock in Xenon Pharmaceuticals Inc.. Dr. Harden has received intellectual property interests from a discovery or technology relating to health care.
Mohammad Ikram	The institution of Mohammad Ikram has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BioGen Inc.
David Himmelstein, MD	No disclosure on file
W. T. Longstreth, Jr., MD, F�鶹��ýӳ��	The institution of Dr. Longstreth has received research support from NIH.
Nutan Sharma, MD, PhD, F�鶹��ýӳ��	Dr. Sharma has nothing to disclose.
Avner Thaler, MD	The institution of Dr. Thaler has received personal compensation in the range of $500-$4,999 for serving as a Consultant for ABBVIE. The institution of Dr. Thaler has received research support from MJFF.
Anthony Traboulsee, MD	Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for EMD Serono. Dr. Traboulsee has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Roche. The institution of Dr. Traboulsee has received research support from Roche. The institution of Dr. Traboulsee has received research support from Consortium of MS Centers. The institution of Dr. Traboulsee has received research support from MS Canada. Dr. Traboulsee has received personal compensation in the range of $500-$4,999 for serving as a Workshop Chair with Consortium of MS Centers.
Shumaila Sultan, MD, F�鶹��ýӳ��	Dr. Sultan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion.
Sophia Sundararajan, MD	Dr. Sundararajan has stock in Boston Scientific Corp. Dr. Sundararajan has stock in Cisco Systems. Dr. Sundararajan has stock in Coca Cola Co. Dr. Sundararajan has stock in Cummins Inc. Dr. Sundararajan has stock in Hartford Insurance group. Dr. Sundararajan has stock in Johnson and Johnson. Dr. Sundararajan has stock in Merck and Company Inc. Dr. Sundararajan has stock in Microsoft. Dr. Sundararajan has stock in Netflix. Dr. Sundararajan has stock in Novartis. Dr. Sundararajan has stock in Oracle Corp. Dr. Sundararajan has stock in Pepsico. Dr. Sundararajan has stock in Proctor and Gamble. Dr. Sundararajan has stock in Qualcomm Inc. Dr. Sundararajan has stock in Travelers Cos Inc. Dr. Sundararajan has stock in Vertex Pharmacueticals. Dr. Sundararajan has stock in Visa Inc. Dr. Sundararajan has stock in Wallmart. Dr. Sundararajan has stock in Zoetis Inc Cl A. The institution of Dr. Sundararajan has received research support from NIH. The institution of Dr. Sundararajan has received research support from AHA.
Andrew Singleton	An immediate family member of Andrew Singleton has received personal compensation for serving as an employee of GeneDx. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Nature Partner Journals Parkinson Disease. Andrew Singleton has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Movement Disorders Journal. An immediate family member of Andrew Singleton has stock in GeneDx. The institution of Andrew Singleton has received research support from Michael J Fox Foundation. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care. Andrew Singleton has received intellectual property interests from a discovery or technology relating to health care.
Anke C. Winter, MD, MSc	No disclosure on file
Alasdair Coles, MD, PhD	Dr. Coles has nothing to disclose.
Joshua Z. Willey, MD, F�鶹��ýӳ��	Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Edwards Scientific. Dr. Willey has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for RECARDIO. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abbott. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BrainQ. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of the American College of Cardiology. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Uptodate. The institution of Dr. Willey has received research support from NIH. Dr. Willey has received personal compensation in the range of $500-$4,999 for serving as a Review chapter author, MKSAP 16-20 with American College of Physicians.
Kenneth W. Sommerville, MD, F�鶹��ýӳ��	No disclosure on file
Christopher Streib, MD	Dr. Streib has nothing to disclose.
Tamara Shiner	Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli lilly. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Eisai. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. Tamara Shiner has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Eisai. The institution of Tamara Shiner has received research support from MJFF.
John H. Sladky, MD, F�鶹��ýӳ��	Dr. Sladky has nothing to disclose.
David G. Munoz, MD	No disclosure on file
Patricia Musolino, MD, PhD	An immediate family member of Dr. Musolino has received personal compensation for serving as an employee of EMD Sorono. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Minoryx Pharmaceuticals. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for IONIS Pharmaceuticals . Dr. Musolino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Inozyme Pharma. Dr. Musolino has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Vertex Pharmaceuticals. An immediate family member of Dr. Musolino has or had stock in 2seventy Bio. An immediate family member of Dr. Musolino has or had stock in Editas Medicine. An immediate family member of Dr. Musolino has or had stock in Generation Bio. An immediate family member of Dr. Musolino has or had stock in Beam Therapeutics. An immediate family member of Dr. Musolino has or had stock in Ebotec . An immediate family member of Dr. Musolino has or had stock in Novonordisk. An immediate family member of Dr. Musolino has or had stock in Morphosys. The institution of Dr. Musolino has received research support from National Institute of Health-NINDS-R01. The institution of Dr. Musolino has received research support from Angea Biotherapeutics. The institution of Dr. Musolino has received research support from Minoryx Pharmaceuticals. The institution of Dr. Musolino has received research support from Belanger Foundation. The institution of Dr. Musolino has received research support from Rozwat Family Foundation. The institution of Dr. Musolino has received research support from Dooley Family Foundation. Dr. Musolino has received intellectual property interests from a discovery or technology relating to health care. Dr. Musolino has received publishing royalties from a publication relating to health care.
Hee Jin Kim, MD	No disclosure on file
Annabel K. Wang, MD, F�鶹��ýӳ��	Dr. Wang has nothing to disclose.
Mohammed S. Sanjak, PhD	No disclosure on file
David E. Stickler, MD	No disclosure on file
Michael P. Macken, MD, MRCPI	Dr. Macken has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Jazz Pharma. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Macken has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for SK LifeSciences. Dr. Macken has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for LivaNova. The institution of Dr. Macken has received research support from LivaNova.
Carlo Pozzilli	Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck. Carlo Pozzilli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alexion.
Simon Warfield	No disclosure on file
Gary Gallagher, MD	Dr. Gallagher has nothing to disclose.
Ammar Ahmed, MBBS, PhD, FRCP, Lond	No disclosure on file
Jennifer N. Serventi, PA	Ms. Serventi has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure.
Alexandra J. Sequeira, MD	Dr. Sequeira has nothing to disclose.
Aparna Wagle-Shukla, MD, F�鶹��ýӳ��	Dr. Wagle-Shukla has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Encora. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Supernus. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Tremor research group. The institution of Dr. Wagle-Shukla has received research support from NIH. Dr. Wagle-Shukla has received personal compensation in the range of $500-$4,999 for serving as a reviewer with NIH.
Jon Rittenberger, MD	No disclosure on file
Maria Esmeralda Quartuccio	No disclosure on file
Samay Jain, MD	No disclosure on file
Larry "LC" Charleston IV, MD, MSc, FAHS, FANA, F�鶹��ýӳ��	Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for AbbVie. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amneal Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Satsuma Pharmaceuticals. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LinPharma. Dr. Charleston has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Haleon. Dr. Charleston has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Pfizer. The institution of Dr. Charleston has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Axsome. Dr. Charleston has or had stock in Mi-Helper Inc..Dr. Charleston has a non-compensated relationship as a Associate Editor with Headache Journal: The Journal of Head and Face Pain that is relevant to �鶹��ýӳ�� interests or activities. Dr. Charleston has a non-compensated relationship as a Board Member with Clinical Neurological Society of America that is relevant to �鶹��ýӳ�� interests or activities. Dr. Charleston has a non-compensated relationship as a Chair, EDI Advisory Committee (Non-voting Board Member) with American Headache Society that is relevant to �鶹��ýӳ�� interests or activities.
Sandra Weintraub, PhD, F�鶹��ýӳ��	Dr. Weintraub has nothing to disclose.
Sibyl E. Wray, MD	Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb/Celgene. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche/Genentech. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi/Genzyme. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Bristol Myers Squibb. Dr. Wray has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for EMD Serono. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche/Genentech. Dr. Wray has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi/Genzyme. The institution of Dr. Wray has received research support from Biogen. The institution of Dr. Wray has received research support from Atara Biotherapeutics. The institution of Dr. Wray has received research support from Bristol Myers Squibb/Celgene. The institution of Dr. Wray has received research support from Novartis. The institution of Dr. Wray has received research support from Roche/Genentech. The institution of Dr. Wray has received research support from Sanofi/Genzyme. The institution of Dr. Wray has received research support from TG Therapeutics. The institution of Dr. Wray has received research support from EMD Serono. The institution of Dr. Wray has received research support from Pharmaceuticals Corp..
Heinz Wiendl, MD, F�鶹��ýӳ��	Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Roche. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Immunovant. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Johnson&Johnson / Janssen. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for UCB. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Idorsia. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Argenx. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Immunic. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Lundbeck. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for LTS. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Samsung. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Dianthus. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for EMD Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for INmune Bio_Syneos Health. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Muna Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Myrobalan Therapeutics. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PSL Group. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Red Nucleus. Dr. Wiendl has received personal compensation in the range of $0-$499 for serving as a Consultant for Swiss Multiple Sclerosis Society. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Teladoc Health. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Toleranzia . Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Viatris. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Wiendl has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bristol Myers Squibb. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sandoz-Hexal. Dr. Wiendl has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Cellerys. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Uniqure. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biocryst. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Galapagos. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Idorsia. Dr. Wiendl has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biontech. The institution of Dr. Wiendl has received research support from Biogen. The institution of Dr. Wiendl has received research support from Roche. The institution of Dr. Wiendl has received research support from Deutsche Forschungsgemeinschaft. The institution of Dr. Wiendl has received research support from European Union. The institution of Dr. Wiendl has received research support from Argenx. The institution of Dr. Wiendl has received research support from CSL Behring. The institution of Dr. Wiendl has received research support from Merck. The institution of Dr. Wiendl has received research support from UCB. Dr. Wiendl has received research support from Alexion Syneos Health iVH UK Ltd.. The institution of Dr. Wiendl has received research support from Deutsche Myasthenie-Gesellschaft. The institution of Dr. Wiendl has received research support from Winicker Norimed GmbH. The institution of Dr. Wiendl has received research support from Novartis. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care. Dr. Wiendl has received publishing royalties from a publication relating to health care.
Joshua P. Klein, MD, PhD, FANA, F�鶹��ýӳ��	Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for SAGE Publishers. Dr. Klein has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for McGraw-Hill Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Oakstone Publishers. Dr. Klein has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wolters Kluwer Publishers. Dr. Klein has received personal compensation in the range of $100,000-$499,999 for serving as an Expert Witness for various law firms. Dr. Klein has received publishing royalties from a publication relating to health care.
Hiroyuki Nodera, MD	No disclosure on file
Glenn T. Stebbins, PhD	Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Partners Healthcare System. Dr. Stebbins has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CHDI. The institution of Dr. Stebbins has received research support from Department of Defense. Dr. Stebbins has received research support from Cleveland Clinic Health Systems. Dr. Stebbins has received personal compensation in the range of $500-$4,999 for serving as a Course Director with MDS.
Jeffrey D. Lewis, MD PhD	No disclosure on file
Donald Johns, MD	No disclosure on file
Nicholas Blondin, MD	Dr. Blondin has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure, Inc.. Dr. Blondin has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Novocure, Inc..
Afraa M. Musa	No disclosure on file
Aaron K. Farrow, MD	No disclosure on file
Anand G. Diwan, MD	No disclosure on file
Reena Ghode, MD, F�鶹��ýӳ��	Dr. Ghode has nothing to disclose.
Guillaume Sebire	No disclosure on file
Mia T. Minen, MD, F�鶹��ýӳ��	The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .
Wildon Farwell, MD	Dr. Farwell has received personal compensation for serving as an employee of Dyne Therapeutics. Dr. Farwell has received personal compensation for serving as an employee of Satellos Biosciences. Dr. Farwell has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Paragon Therapeutics. Dr. Farwell has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Farwell has or had stock in Dyne Therapeutics.Dr. Farwell has or had stock in Satellos Bioscience.
Anto Bagic, MD, PhD	Dr. Bagic has nothing to disclose.
Roy E. Strowd III, MD, F�鶹��ýӳ��	Dr. Strowd has received personal compensation for serving as an employee of Kaplan. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Monteris Medical, Inc. Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novocure. The institution of Dr. Strowd has received personal compensation in the range of $500-$4,999 for serving as a Consultant for SpringWorks . Dr. Strowd has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��. The institution of Dr. Strowd has received research support from Southeastern Brain Tumor Foundation. The institution of Dr. Strowd has received research support from Jazz Pharmaceuticals. The institution of Dr. Strowd has received research support from National Institutes of Health. The institution of Dr. Strowd has received research support from Alpha Omega Alpha. The institution of Dr. Strowd has received research support from American Board of Psychiatry and Neurology. Dr. Strowd has received publishing royalties from a publication relating to health care. Dr. Strowd has received publishing royalties from a publication relating to health care.
Steve W. Han, MD PhD	No disclosure on file
Hasan Sonmezturk, MD	No disclosure on file
Maria J. Melanson, MD	No disclosure on file
Max R. Lowden, MD, F�鶹��ýӳ��	Dr. Lowden has nothing to disclose.
Amar Bhatt, MD, F�鶹��ýӳ��	No disclosure on file
Anthony P. Nicholas, MD, PhD	Dr. Nicholas has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Fenwick. Dr. Nicholas has received publishing royalties from a publication relating to health care.
Guillermo Izquierdo Ayuso, MD	Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bayer, Biogen Idec, Novartis, Sanofi, Merck Serono, Roche, Actelion and Celgene. Dr. Izquierdo Ayuso has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genzyme, Novartis, Sanofi Aventis, Alexion.
Madalina Chirieac, MD	No disclosure on file
Gobinathan Devathasan, MD, F�鶹��ýӳ��	No disclosure on file
Viviane H. Zetola, MD	Dr. Zetola has nothing to disclose.
Annette Okai, MD, F�鶹��ýӳ��	Dr. Okai has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for Genentech. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi Genzyme. Dr. Okai has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for EMD Serono. Dr. Okai has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Sanofi Genzyme . The institution of Dr. Okai has received research support from Sanofi Genzyme. The institution of Dr. Okai has received research support from Roche Genetech. The institution of Dr. Okai has received research support from Novartis. The institution of Dr. Okai has received research support from EMD Serono. The institution of Dr. Okai has received research support from TG Therapeutics.
Nicholas A. Morris, MD, F�鶹��ýӳ��	The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. The institution of Dr. Morris has received research support from �鶹��ýӳ��. The institution of Dr. Morris has received research support from National Institute of Neurological Disorders and Stroke. Dr. Morris has received personal compensation in the range of $500-$4,999 for serving as a Webinar Speaker with Kreg Therapeutics. Dr. Morris has a non-compensated relationship as a Editorial Board Member with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities. Dr. Morris has a non-compensated relationship as a Editorial Board Member with Neurocritical Care Society that is relevant to �鶹��ýӳ�� interests or activities.
Samar F. Ahmed, MD	Dr. Ahmed has nothing to disclose.
Thomas Wychowski, MD	The institution of Dr. Wychowski has received research support from UCB.
Marshall S. Balish, MD, PhD	No disclosure on file
Stacy V. Smith, MD	Dr. Smith has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Teva. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for TEVA . Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. Dr. Smith has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Abbvie. Dr. Smith has received publishing royalties from a publication relating to health care.
Lauren V. DeNiro, MD	No disclosure on file
Erin E. Carlson, MD	No disclosure on file
Sarah Song, MD, MPH, F�鶹��ýӳ��	Dr. Song has received personal compensation in the range of $50,000-$99,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��.
Carsten Lukas, MD	No disclosure on file
David Cella, PhD	No disclosure on file
Ajay M. Tunguturi, MD	Dr. Tunguturi has nothing to disclose.
Bhavesh Trikamji, MD	Dr. Trikamji has nothing to disclose.
Ying Liu, PhD	No disclosure on file
George H. Jackson, MD	No disclosure on file
David J. Sharp, MD	No disclosure on file
Andrea Harriott, MD	Dr. Harriott has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Theranica. Dr. Harriott has received personal compensation in the range of $5,000-$9,999 for serving as an officer or member of the Board of Directors for Headache Cooperative of New England. The institution of Dr. Harriott has received research support from Electrocore. Dr. Harriott has a non-compensated relationship as a Author agreement with Abbvie that is relevant to �鶹��ýӳ�� interests or activities. Dr. Harriott has a non-compensated relationship as a Researcher/Receipt of drug with Praxis that is relevant to �鶹��ýӳ�� interests or activities.
Daphne Robakis, MD	Dr. Robakis has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amneal pharmaceuticals.
Jose R. Romero, MD	The institution of Dr. Romero has received research support from NIH/NIA.
Pichet Termsarasab, MD	No disclosure on file
Muhammad M. Alvi, MD, F�鶹��ýӳ��	Dr. Alvi has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Brainomix.
Klemens Winder, MD	No disclosure on file
Valerie A. Cwik, MD	No disclosure on file
Jasem Y. Al-Hashel, MD	Dr. Al-Hashel has nothing to disclose.
Simon Broadley, PhD, FRACP	The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. The institution of Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. The institution of Dr. Broadley has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Merck. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Broadley has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Sage. The institution of Dr. Broadley has received research support from NHMRC. The institution of Dr. Broadley has received research support from ARC. The institution of Dr. Broadley has received research support from GCH Foundation. The institution of Dr. Broadley has received research support from NHMRC.
Yi-Chu Liao, MD	Dr. Liao has nothing to disclose.
Kendra Peterson, MD	No disclosure on file
Annett Kunkel	No disclosure on file
Jing Wang, MD	No disclosure on file
Abdelrahman Beltagy, MD	Dr. Beltagy has nothing to disclose.
Giovanna Borriello	Giovanna Borriello has nothing to disclose.
Kunihiko Asakura, MD, PhD	No disclosure on file
Elizabeth T. Kinter, PhD	No disclosure on file
Ezgi Tiryaki, MD, F�鶹��ýӳ��	Dr. Tiryaki has or had stock in HITIT Leadership Coaching.Dr. Tiryaki has a non-compensated relationship as a Professor of Neurology with University of Minnesota that is relevant to �鶹��ýӳ�� interests or activities. Dr. Tiryaki has a non-compensated relationship as a Clinic Director of a Center of Excellence with The ALS Association that is relevant to �鶹��ýӳ�� interests or activities. Dr. Tiryaki has a non-compensated relationship as a Volunteer Clinical Neurologist at ALS Clinic with Minneapolis VA Healthcare System that is relevant to �鶹��ýӳ�� interests or activities.
Melissa L. Rayhill, MD, F�鶹��ýӳ��	Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Headache Cooperative of New England. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with Clusterbusters. Dr. Rayhill has received personal compensation in the range of $500-$4,999 for serving as a Presenter with �鶹��ýӳ��.
Harshit Shah, MD	No disclosure on file
Tatsuro M. Mutoh, MD, PhD, F�鶹��ýӳ��	Dr. Mutoh has nothing to disclose.
Sebastian F. Von Rosenstiel, MD, PhD	Dr. Von Rosenstiel has received personal compensation for serving as an employee of Takeda. Dr. Von Rosenstiel has stock in Takeda.
Donna Tippett	No disclosure on file
Jonas A. Vanags, MD	No disclosure on file
Warren Darling	No disclosure on file
Teri R. Thomsen, MD	Dr. Thomsen has nothing to disclose.
Jun Mitsui	No disclosure on file
Kelly Baldwin, MD	Dr. Baldwin has nothing to disclose.
Leah R. Hanson, PhD	The institution of Dr. Hanson has received research support from NIA. The institution of Dr. Hanson has received research support from Merck Foundation. The institution of Dr. Hanson has received research support from Eagle Pharmaceuticals. The institution of Dr. Hanson has received research support from Research Grow Lab. The institution of Dr. Hanson has received research support from State of Minnesota. Dr. Hanson has received intellectual property interests from a discovery or technology relating to health care.
Joel Kline	No disclosure on file
David H. Margolin, MD, PhD	Dr. Margolin has received personal compensation for serving as an employee of uniQure, Inc.. Dr. Margolin has stock in Cerevance, Inc. Dr. Margolin has stock in Datacubed Health. Dr. Margolin has stock in uniQure, Inc.. Dr. Margolin has received intellectual property interests from a discovery or technology relating to health care.
Raghav Govindarajan, MD, F�鶹��ýӳ��	Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for MT pharma. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Catalyst. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sarepta. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amicus. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MT pharma . Dr. Govindarajan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Catalyst. Dr. Govindarajan has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Biohaven. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Takeda. Dr. Govindarajan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Abbvie. The institution of Dr. Govindarajan has received research support from Band of Hope . The institution of Dr. Govindarajan has received research support from Alexion. Dr. Govindarajan has received publishing royalties from a publication relating to health care.
Anuradha Duleep, MD	Dr. Duleep has nothing to disclose.
Sheetal Shroff, MD	Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Astra Zeneca. Dr. Shroff has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. Dr. Shroff has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Argenx.
Ermelinda De Meo	Ms. De Meo has nothing to disclose.
Rhonda Friedman, PhD	No disclosure on file
David L. Perez, MD, F�鶹��ýӳ��	Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Wiley: Brain and Behavior. Dr. Perez has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for American Psychiatric Association Publishing. The institution of Dr. Perez has received research support from NIH. The institution of Dr. Perez has received research support from Sidney R. Baer Jr. Foundation. The institution of Dr. Perez has received research support from Warren Alpert Foundation. Dr. Perez has received publishing royalties from a publication relating to health care. Dr. Perez has received publishing royalties from a publication relating to health care.
Sandra L. Helmers, MD, F�鶹��ýӳ��	No disclosure on file
Li Yan	No disclosure on file
David J. Thurman, MD, F�鶹��ýӳ��	No disclosure on file
Jonathan Howard, MD	Dr. Howard has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for MCE Conferences. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has received publishing royalties from a publication relating to health care. Dr. Howard has a non-compensated relationship as a Test writer with ABPN that is relevant to �鶹��ýӳ�� interests or activities.
Adam M. Willis, MD	The institution of Dr. Willis has received research support from Air Force. Dr. Willis has received intellectual property interests from a discovery or technology relating to health care.
Lynn Kataria, MD	Dr. Kataria has nothing to disclose.
Joseph I. Petrsoric, MD	No disclosure on file
Angela M. Malek, PhD	No disclosure on file
Babar Khokhar, MD, F�鶹��ýӳ��	Dr. Khokhar has nothing to disclose.
Larry S. Ivanco	No disclosure on file
Seiji Kaji	No disclosure on file
Neeta S. Duggal, MD	No disclosure on file
Jeremy N. Rich, MD	No disclosure on file
Ryosuke Miyamoto, MD	No disclosure on file
Martina Absinta, MD	Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Absinta has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abata Therapeutics. The institution of Dr. Absinta has received research support from International MS Alliance. The institution of Dr. Absinta has received research support from FRRB Early Career Award. The institution of Dr. Absinta has received research support from Cariplo Foundation.
Joseph Y. Kim, MD	No disclosure on file
Ahmed M. Yassin, MD	Dr. Yassin has nothing to disclose.
Ramon Gil, MD	No disclosure on file
Sankar P. Gorthi, MD, F�鶹��ýӳ��	Dr. Gorthi has nothing to disclose.
Nikita Jain, MD	Dr. Jain has nothing to disclose.
Takayuki Kosaka, MD, PhD	Dr. Kosaka has nothing to disclose.
Asuri N. Prasad, MD, FRCPC	No disclosure on file
Yuishin Izumi, MD, PhD	No disclosure on file
Brian Mac Grory, MB BCh BAO	An immediate family member of Dr. Mac Grory has received personal compensation for serving as an employee of Sanofi. Dr. Mac Grory has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke. The institution of Dr. Mac Grory has received research support from National Institutes of Health. The institution of Dr. Mac Grory has received research support from American Heart Association.
Araki Wataru, MD, PhD	No disclosure on file
Hyemin Jang, MD	No disclosure on file
Mahmoud A. AbdelRazek, MD	Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. AbdelRazek has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Biogen. Dr. AbdelRazek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG therapeutics.
Joshua Alexander, DO, MPH	No disclosure on file
Alexandra T. Roach, MD	No disclosure on file
Catherine A. Madison, MD	No disclosure on file
David L. White, MD	No disclosure on file
Richard Libman, MD, F�鶹��ýӳ��	Dr. Libman has nothing to disclose.
Ryan D. Jacobson, MD	Dr. Jacobson has nothing to disclose.
Amro Stino, MD	Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for CSL Behring. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Stino has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Dr. Stino has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Annexon. The institution of Dr. Stino has received research support from GBS-CIDP Foundation. The institution of Dr. Stino has received research support from Bristol Myers Squibb.
Hadi M. Mohammad Khanli, MD	Dr. Mohammad Khanli has nothing to disclose.
Ishan Adhikari, MD, F�鶹��ýӳ��	No disclosure on file
Travis R. Taylor, MD	Dr. Taylor has nothing to disclose.
Ian Miller, MD	Dr. Miller has received personal compensation for serving as an employee of Marinus Pharmaceuticals. Dr. Miller has stock in Marinus Pharmaceuticals.
Jeffrey M. Katz, MD	Dr. Katz has received personal compensation in the range of $50,000-$99,999 for serving as an Expert Witness for Katz Medical Consulting. The institution of Dr. Katz has received research support from Medtronic.
Alex Rovira	Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofy. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers. Alex Rovira has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bayer. Alex Rovira has stock in Tensor Medical.
Ingrid E. Scheffer, MBBS, PhD, FRACP, AO	Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biohaven Pharmaceuticals, Inc. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Longboard Pharmaceuticals . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for UCB. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Consultant for Biocodex. Dr. Scheffer has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Bellberry Ltd. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Medical Research Future Fund, Australia. The institution of Dr. Scheffer has received research support from Einstein Visiting Fellowship. The institution of Dr. Scheffer has received research support from National Health and Medical Research Council, Australia. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received intellectual property interests from a discovery or technology relating to health care. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Akumentis. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Biocodex. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Chiesi . Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Travel/Conference/Speaker honoraria with Stoke Therapeutics. Dr. Scheffer has received personal compensation in the range of $0-$499 for serving as a Speaker honoraria with Zuellig Pharma Inc.. Dr. Scheffer has a non-compensated relationship as a Trial Investigator with Anavex Life Sciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerebral Therapeutics that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cerecin that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Cereval Therapeutics that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Biohaven Ltd. that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Scientific Advisory Board, Trial investigator with Encoded Therapeutics that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with EpiMinder Inc that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with ES-Therapeutics that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Bright Minds Biosciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Marinus Pharmaceuticals that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neurocrine BioSciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Neuren Pharmaceuticals that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Praxis Precision Medicines that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator, Scientific Advisory Board with Takeda Pharmaceuticals that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Xenon Pharmaceuticals that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Zogenix that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Neurology that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Epileptic Disorders that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with Progress in Epileptic Disorders series that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Journal Editorial Board with The Lancet Neurology that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Australian Academy of Health and Medical Sciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Director with Royal Society (Australia). that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Shanghai Zhimeng Biopharma that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with SK Life Science that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Supernus Pharmaceuticals that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with UCB Biopharma SRL that is relevant to �鶹��ýӳ�� interests or activities. Dr. Scheffer has a non-compensated relationship as a Trial investigator with Ultragenyx that is relevant to �鶹��ýӳ�� interests or activities.
Amanda L. Piquet, MD, F�鶹��ýӳ��	The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Kyverna . The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech/Roche. The institution of Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Kyverna. The institution of Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Sands Anderson PC. Dr. Piquet has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Joe Jones Law Firm. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Cortez & Associates. Dr. Piquet has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Falk Waas. The institution of Dr. Piquet has received research support from Rocky Mountain MS Center. The institution of Dr. Piquet has received research support from Roche/Genentech. The institution of Dr. Piquet has received research support from NYU. The institution of Dr. Piquet has received research support from Anokion. The institution of Dr. Piquet has received research support from UCB . The institution of Dr. Piquet has received research support from Foundation for Sarcoidosis. The institution of Dr. Piquet has received research support from Kyverna . Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received publishing royalties from a publication relating to health care. Dr. Piquet has received personal compensation in the range of $10,000-$49,999 for serving as a Litigative Consultant with US-Dept HHS/DICP. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Autoimmune Encephalitis Alliance (AEA) that is relevant to �鶹��ýӳ�� interests or activities. Dr. Piquet has a non-compensated relationship as a Medical Advisory Board Member with Stiff Person Syndrome Research Foundation (SPSRF) that is relevant to �鶹��ýӳ�� interests or activities.
Mohamad A. Mikati, MD	No disclosure on file
Kailin Yang	No disclosure on file
Daniel C. Abenroth, MD	Dr. Abenroth has nothing to disclose.
Eric D. Marsh, MD, PhD	Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmacuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from NIH. The institution of Dr. Marsh has received research support from Rett Syndrome Research Trust. The institution of Dr. Marsh has received research support from International Rett Syndrome Foundation. The institution of Dr. Marsh has received research support from Eagles Autism Challenge. The institution of Dr. Marsh has received research support from LouLou Foundation. The institution of Dr. Marsh has received research support from International CDKL5 Resarch Foundation. The institution of Dr. Marsh has received research support from Acadia Pharmaceuticals. The institution of Dr. Marsh has received research support from Marinus. The institution of Dr. Marsh has received research support from Stoke Therapeutics. The institution of Dr. Marsh has received research support from Takeda Pharmaceuticals. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Grant Review with NIH. Dr. Marsh has received personal compensation in the range of $5,000-$9,999 for serving as a Expert Witness with Department of Human Services. Dr. Marsh has received personal compensation in the range of $500-$4,999 for serving as a Speaker with Medscape.
Elizabeth Thiele, MD	Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for GW Pharma/Jazz. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for zogenix/UCB. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for nobelpharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for livanova. Dr. Thiele has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Noema Pharma. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving as a Consultant for pyros pharmaceutical/upsher smith. Dr. Thiele has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Marinus Pharmaceuticals. The institution of Dr. Thiele has received research support from GW Pharma/Jazz. The institution of Dr. Thiele has received research support from Zogenix/UCB. The institution of Dr. Thiele has received research support from Stoke Therapeutics. The institution of Dr. Thiele has received research support from Biocodex. Dr. Thiele has received publishing royalties from a publication relating to health care.
Orrin Devinsky, MD, F�鶹��ýӳ��	Dr. Devinsky has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for California Cannabis Enterprises. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Privateer Holdings. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Receptor Holdings. Dr. Devinsky has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rettco. Dr. Devinsky has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Silver Spike. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Tevard. Dr. Devinsky has received personal compensation in the range of $1,000,000+ for serving on a Scientific Advisory or Data Safety Monitoring board for Tilray. Dr. Devinsky has received personal compensation in the range of $100,000-$499,999 for serving as an officer or member of the Board of Directors for Engage. Dr. Devinsky has received personal compensation in the range of $50,000-$99,999 for serving as an officer or member of the Board of Directors for Tevard Biosciences. Dr. Devinsky has stock in Engage. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in California Cannabis Enterprises. Dr. Devinsky has stock in Empatica. Dr. Devinsky has stock in Silver Spike. Dr. Devinsky has stock in Docklight Brands. Dr. Devinsky has stock in Egg Rock/Papa Barkley. Dr. Devinsky has stock in Leafly. Dr. Devinsky has stock in Left Coast Ventures. Dr. Devinsky has stock in Privateer Holdings. Dr. Devinsky has stock in Receptor Holdings. Dr. Devinsky has stock in Qstate. The institution of Dr. Devinsky has received research support from GW Pharma. The institution of Dr. Devinsky has received research support from Zogenix. The institution of Dr. Devinsky has received research support from PTC Pharma. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from DOD. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from Epilepsy Foundation. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NIH. The institution of Dr. Devinsky has received research support from NSF. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received intellectual property interests from a discovery or technology relating to health care. Dr. Devinsky has received publishing royalties from a publication relating to health care.
Olga Ciccarelli, MD, PhD, FRCP	Prof. Ciccarelli has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Prof. Ciccarelli has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEUROLOGY Journal.
Judd M. Jensen, MD	Dr. Jensen has nothing to disclose.
Robert N. Sawyer, Jr., MD	Dr. Sawyer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Medtronic. Dr. Sawyer has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Leven Gouldin and Thompson.
Leslie H. Lee, MD, F�鶹��ýӳ��	Dr. Lee has nothing to disclose.
Carmen M. Martinez, MD	No disclosure on file
Leslie R. Blackshear	No disclosure on file
Christine Saint-Martin	No disclosure on file
Marwan Alahiri	No disclosure on file
David E. Blum, MD	Dr. Blum has received personal compensation for serving as an employee of Neurona Therapeutics. Dr. Blum has stock in Neurona Therapeutics.
Stephen J. Ryan, MD	No disclosure on file
Perrin A. Pleninger, MD, F�鶹��ýӳ��	Dr. Pleninger has nothing to disclose.
Jong-Ling Fuh, MD, F�鶹��ýӳ��	Dr. Fuh has nothing to disclose.
Robert P. Rubens, MD, MBA, F�鶹��ýӳ��	Dr. Rubens has received personal compensation for serving as an employee of Takeda Pharmaceuticals. Dr. Rubens has received stock or an ownership interest from Takeda Pharmaceuticals.
Hong K. Song, MD	No disclosure on file
Linda Laux, MD	Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. Dr. Laux has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biocodex.
Paul Wright, MD, F�鶹��ýӳ��	Dr. Wright has nothing to disclose.
Rohit Dhall, MD, F�鶹��ýӳ��	Dr. Dhall has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Best Doctors Inc. Dr. Dhall has stock in Verve Therapeutics Inc. Dr. Dhall has stock in Roche Holding Limited. Dr. Dhall has stock in Enliven Therapeutics Inc. The institution of Dr. Dhall has received research support from Amneal. The institution of Dr. Dhall has received research support from Neuroderm. The institution of Dr. Dhall has received research support from Cerevel Therapeutics. The institution of Dr. Dhall has received research support from Neurocrine. The institution of Dr. Dhall has received research support from Neuraly. The institution of Dr. Dhall has received research support from SPARC. The institution of Dr. Dhall has received research support from Pharma2B. The institution of Dr. Dhall has received research support from Alexion. The institution of Dr. Dhall has received research support from Parkinsons Foundation. The institution of Dr. Dhall has received research support from UCB Pharma. The institution of Dr. Dhall has received research support from Inhibikase Therapeutics. The institution of Dr. Dhall has received research support from Amylyx Pharma.
Ajay Verma, MD, PhD	No disclosure on file
Eric M. Wassermann, MD	No disclosure on file
Stephen Lee, MD, PhD	No disclosure on file
Maria E. Baldwin, MD	Dr. Baldwin has nothing to disclose.
Alexandra M. Miller, MD	Dr. Miller has received personal compensation in the range of $500-$4,999 for serving as a Consultant for GSK. Dr. Miller has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Modifi Biosciences.
Elena Ratti, MD	Dr. Ratti has received personal compensation for serving as an employee of Takeda. Dr. Ratti has received personal compensation for serving as an employee of Biogen. Dr. Ratti has stock in Takeda. Dr. Ratti has stock in Biogen.
Christopher D. Stephen, MB ChB, FRCP, MSc, SM	The institution of Dr. Stephen has received research support from Sanofi. Dr. Stephen has received research support from National Institutes of Health.
Paolo Preziosa	Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Bristol Myers Squibb . Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi Genzyme. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Mr. Preziosa has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Seung-Han Suk, MD	No disclosure on file
Ann D. Bass, MD	Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen, Alexion, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. Dr. Bass has received personal compensation in the range of $100,000-$499,999 for serving on a Speakers Bureau for Alexion, Amgen, Bristol-Myers-Squibb, EMD Serono, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics. The institution of Dr. Bass has received research support from Bristol-Myers-Squibb, EMD Serono, Novartis, Roche-Genentech, Sanofi-Genzyme, TG Therapeutics.
Luis A. Chui, MD	No disclosure on file
Dominic B. Rowe, MBBS, PhD	No disclosure on file
Frank Bennett, PhD	No disclosure on file
Anna Ranta, MD, PhD, FRACP, F�鶹��ýӳ��	The institution of Dr. Ranta has received research support from Health Research Council of New Zealand. The institution of Dr. Ranta has received research support from New Zealand Ministry of Health. The institution of Dr. Ranta has received research support from New Zealand Neurological Foundation. Dr. Ranta has a non-compensated relationship as a Treasurer with Stroke Society of Australasia that is relevant to �鶹��ýӳ�� interests or activities. Dr. Ranta has a non-compensated relationship as a Board Member with World Stroke Organisation that is relevant to �鶹��ýӳ�� interests or activities. Dr. Ranta has a non-compensated relationship as a President with Neurological Association of new Zealand that is relevant to �鶹��ýӳ�� interests or activities. Dr. Ranta has a non-compensated relationship as a Editorial Board Member with 'Stroke' and 'Neurology' (Journals) that is relevant to �鶹��ýӳ�� interests or activities.
Jason Massa, DO, F�鶹��ýӳ��	Dr. Massa has nothing to disclose.
Philippe Truffinet, MD	Dr. Truffinet has received personal compensation for serving as an employee of Sanofi.
Lawrence M. Samkoff, MD, F�鶹��ýӳ��	Dr. Samkoff has nothing to disclose.
Charles A. Szabo, MD, F�鶹��ýӳ��	Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for LivaNova. Dr. Szabo has received personal compensation in the range of $500-$4,999 for serving as an officer or member of the Board of Directors for Epilepsy Foundation of Central and South Texas. Dr. Szabo has received personal compensation in the range of $0-$499 for serving as a Reviewer with NINDS.
Edwin B. George, MD, PhD, F�鶹��ýӳ��	No disclosure on file
Erica Selheimer, MD	No disclosure on file
Shuu-Jiun Wang, MD	Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Eli-Lilly. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Norvatis. Dr. Wang has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for AbbVie. Dr. Wang has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Pfizer, Taiwan. The institution of Dr. Wang has received research support from Eli-Lilly. The institution of Dr. Wang has received research support from Norvatis.
Ruggero Capra, MD	Dr. Capra has nothing to disclose.
Brandon E. Beaber, MD	No disclosure on file
Yuri Bronstein, MD	Dr. Bronstein has nothing to disclose.
Luiz H. Castro, MD	Dr. Castro has nothing to disclose.
Massimiliano Copetti	No disclosure on file
Bianca A. Ulloa	No disclosure on file
Matthew H. Wong, MD	No disclosure on file
Brian Steingo, MD	Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. Dr. Steingo has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen, EMD Serono, Bristol Myers, Sanofi, Janssen. The institution of Dr. Steingo has received research support from Infinity Clinical Research.
Neville Jadeja, MD, MPH	No disclosure on file
Nicholas W. Wood	No disclosure on file
Mark D. Johnson, MD	Dr. Johnson has nothing to disclose.
Yoshie Umemura, MD, F�鶹��ýӳ��	Dr. Umemura has received personal compensation for serving as an employee of Barrow Neurological Institute. Dr. Umemura has received personal compensation for serving as an employee of University of Michigan. Dr. Umemura has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Guidepoint. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Qessential. Dr. Umemura has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Servier. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with Curio Science LLC. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with OncLive. Dr. Umemura has received personal compensation in the range of $500-$4,999 for serving as a Honorarium with MJH Life Sciences.
Barry A. Singer, MD	Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Alexion. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Genentech. Dr. Singer has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novartis. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Sanofi. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving as a Consultant for TG Therapeutics. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amgen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Biogen. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Bristol Myers Squibb (Celgene). Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for EMD Serono. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Novartis. Dr. Singer has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Singer has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Vanda. An immediate family member of Dr. Singer has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Singer has received research support from Novartis. The institution of Dr. Singer has received research support from Sanofi. The institution of Dr. Singer has received research support from TG Therapeutics. The institution of Dr. Singer has received research support from Bristol Myers Squibb.
Shyam S. Moudgil, MD, F�鶹��ýӳ��	Dr. Moudgil has nothing to disclose.
Kathryn A. Chung, MD	The institution of Dr. Chung has received research support from Department of Veteran's Affairs.
Goran Rakocevic, MD, F�鶹��ýӳ��	Dr. Rakocevic has nothing to disclose.
Sarah Gheuens, MD	No disclosure on file
Eoin P. Flanagan, MBBCh, F�鶹��ýӳ��	The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to �鶹��ýӳ�� interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to �鶹��ýӳ�� interests or activities.
Jonathan Perk, MD, PhD, F�鶹��ýӳ��	Dr. Perk has nothing to disclose.
Massimiliano Cristofanilli, PhD	No disclosure on file
Samuel Lapalme-Remis, MD	Dr. Lapalme-Remis has nothing to disclose.
Adam Ziemann, MD, PhD	Dr. Ziemann has received personal compensation for serving as an employee of AbbVie. Dr. Ziemann has received stock or an ownership interest from AbbVie.
Claire E. Carrazco, DO	No disclosure on file
Alvino Bisecco	Alvino Bisecco has nothing to disclose.
Padmaja Sudhakar, MD	Dr. Sudhakar has nothing to disclose.
Mika Komori	Mika Komori has received personal compensation for serving as an employee of Eli Lilly K.K..
Christopher McAulay-Powell, MD	No disclosure on file
David Bar-Or	David Bar-Or has received intellectual property interests from a discovery or technology relating to health care.
Megan M. Baumgardner, DO	No disclosure on file
Forrest J. Lowe, MD	Dr. Lowe has nothing to disclose.
Diviya Kaul, MD	Dr. Kaul has nothing to disclose.
Mary Kay Floeter, MD, PhD	No disclosure on file
Mark Agostini, MD	Dr. Agostini has nothing to disclose.
Kan Ding, MD	The institution of Dr. Ding has received research support from National Institute of Aging. The institution of Dr. Ding has received research support from NINDS.
Guido Sabatella	Guido Sabatella has received personal compensation for serving as an employee of Alexion.
Louis A. Tramontozzi III, MD, F�鶹��ýӳ��	Dr. Tramontozzi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Downs, Rachlin, Martin. Dr. Tramontozzi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Mirick O'Connell, DeMallie & Lougee, LLP. Dr. Tramontozzi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for CRICO. Dr. Tramontozzi has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Foster & Eldridge LLP.
Anila Thomas, MD	Dr. Thomas has nothing to disclose.
Samuel J. Cohn, MD	No disclosure on file
Johanna Hamel, MD	Dr. Hamel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Vertex Pharmaceuticals.
Divyanshu Dubey, MD, F�鶹��ýӳ��	The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Argenx. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Arialys. The institution of Dr. Dubey has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from Department of Defense . Dr. Dubey has received research support from UCB. Dr. Dubey has received research support from David J. Tomassoni ALS Research Grant Program . Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care. Dr. Dubey has received intellectual property interests from a discovery or technology relating to health care.
Charlotte E. Zisman, MD	No disclosure on file
Evanthia Bernitsas, MD, F�鶹��ýӳ��	Dr. Bernitsas has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Amgen. Dr. Bernitsas has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Vanda. The institution of Dr. Bernitsas has received research support from Roche/Genentech.
Scheherazade Le, MD	Dr. Le has nothing to disclose.
Takashi Kageyama, MD, PhD	No disclosure on file
Yen-Yu Chen, MD	No disclosure on file
Takuya Konno, MD, PhD	No disclosure on file
Shawn Zardouz, MD	No disclosure on file
Himanshu Chokhawala, MD	Dr. Chokhawala has nothing to disclose.
Jaydeep M. Bhatt, MD	Dr. Bhatt has nothing to disclose.
Shu-Ching Hu, MD	No disclosure on file
Michael J. Lyerly, MD, F�鶹��ýӳ��	Dr. Lyerly has nothing to disclose.
Amre Nouh, MD, F�鶹��ýӳ��	Dr. Nouh has stock in Openwater.
Altaf Saadi, MD, MSc, F�鶹��ýӳ��	The institution of Dr. Saadi has received research support from National Science Foundation. The institution of Dr. Saadi has received research support from National Institute of Health. The institution of Dr. Saadi has received research support from Dana Foundation. Dr. Saadi has received research support from �鶹��ýӳ��.
Supriya Mahajan, MD	Dr. Mahajan has nothing to disclose.
Alessandro D'Ambrosio	No disclosure on file
Akihiko Ozaki, MD, PhD	No disclosure on file
Jae Hyeon Park, MD	No disclosure on file
Jan N. Lycke, MD	Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Celgene. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Janssen. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Lycke has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. Dr. Lycke has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for GeNeuro. The institution of Dr. Lycke has received research support from Sanofi.
Ryan Hays, MD, MBA, FAES, F�鶹��ýӳ��	Dr. Hays has nothing to disclose.
Jessica L. Winslow, MD	No disclosure on file
Babatunde A. Ademiluyi, MD	No disclosure on file
Jacqueline Palace	Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Merck Serono, Medimmune, Argenx, Janssen, AMgen, UCB, Roche, Novartis, Amplo, Alexion, . Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx, Sanofi. Dr. Palace has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Roche, UCB, Alexion, Amgen. Dr. Palace has or had stock in Astra Zenica. The institution of Dr. Palace has received research support from Roche, AMPLO, Alexion, UCB,. argenx, amgen. Dr. Palace has received intellectual property interests from a discovery or technology relating to health care.
Luca Prosperini, MD	No disclosure on file
Lei Shi, MD	No disclosure on file
Tyler R. West, DO	No disclosure on file
Jun Hong Lee, MD	No disclosure on file
Navid Seraji-Bozorgzad, MD	No disclosure on file
Mona C. Thakre, MD, F�鶹��ýӳ��	Dr. Thakre has nothing to disclose.
Hunan A. Chaudhry, MD	No disclosure on file
Keren Regev, MD	Dr. Regev has nothing to disclose.
Ramesh Nayak	No disclosure on file
Sung-Hee Hwang	No disclosure on file
Safdar Ansari, MD	Dr. Ansari has nothing to disclose.
Russell M. Cerejo, MD	Dr. Cerejo has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ischemaview.
Krzysztof W. Selmaj	Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Astra. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for BMS. Krzysztof W. Selmaj has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Christopher Fanale, MD	No disclosure on file
Marta Radaelli	Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Merck Serono. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Biogen. Marta Radaelli has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Marta Radaelli has received personal compensation in the range of $0-$499 for serving on a Speakers Bureau for Sanofi-Genzyme.
Abdulradha Alqallaf, MD	Dr. Alqallaf has nothing to disclose.
Fulton Velez	No disclosure on file
Ashkan Mowla, MD, F�鶹��ýӳ��	No disclosure on file
Matthew B. Freeman, MD	No disclosure on file
Sirwan K. Darweesh, MD, PhD	No disclosure on file
Im-Seok Koh	No disclosure on file
Edward J. Gettings, DO	Dr. Gettings has nothing to disclose.
Tirisham Gyang, MD	Dr. Gyang has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for EMD Serono.
Sheridan Reed	No disclosure on file
Mario Habek, MD	Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck . Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Astra Zeneca. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Roche. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Biogen. Dr. Habek has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Merck.
Susumu Kusunoki	No disclosure on file
Minsoo Kim, MD	No disclosure on file
Lauren E. Dunn, MD	Dr. Dunn has nothing to disclose.
Susan A. Eaton, PharmD	No disclosure on file
Ram C. Gowda, MD	Dr. Gowda has nothing to disclose.
Andrea C. Wasilewski, MD	Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Novocure. Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Servier Pharmaceuticals . Dr. Wasilewski has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Jazz Pharmaceuticals .
Davida Goltz, MD	No disclosure on file
Drago Bratkovic	Drago Bratkovic has nothing to disclose.
Gobind Singh, MBBS	No disclosure on file
Adil Iqbal, MD	No disclosure on file
Jeffrey Jian	No disclosure on file
Kanita Beba Abadal, MD	Dr. Beba has nothing to disclose.
Heather Newman	No disclosure on file
Jerome De Seze	Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma. Jerome De Seze has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Pharma.
Jennifer L. Nichols, MD	No disclosure on file
Tiana E. Cruz	No disclosure on file
Brian J. Hanrahan, MD	Dr. Hanrahan has received personal compensation for serving as an employee of Nowyouknow Neuro.
Chakri Gavva, MD	No disclosure on file
Lakshmi Warrior, MD, F�鶹��ýӳ��	Dr. Warrior has nothing to disclose.
Jafar Kafaie, MD, PhD, F�鶹��ýӳ��	Dr. Kafaie has nothing to disclose.
Mat D. Davis	Mat D. Davis has received personal compensation for serving as an employee of Teva pharmaceuticals. Mat D. Davis has received stock or an ownership interest from Teva Pharmaceuticals.
Jihad S. Inshasi, MD, MBBS, F�鶹��ýӳ��	Dr. Inshasi has nothing to disclose.
Kathie M. Bishop, PhD	Dr. Bishop has received personal compensation for serving as an employee of Acadia Pharmaceuticals, Inc. . Dr. Bishop has received personal compensation in the range of $10,000-$49,999 for serving as an officer or member of the Board of Directors for DTx Pharma. Dr. Bishop has stock in Acadia Pharmaceuticals, Inc..
Stephen A. Trevick, MD	No disclosure on file
Ruihao Wang, MD	Dr. Wang has nothing to disclose.
Laurence Mignon, PhD	No disclosure on file
Vanessa White	No disclosure on file
Russell A. Kern, PhD	No disclosure on file
Hailong Cheng	No disclosure on file
Alexandra S. Reynolds, MD	Dr. Reynolds has nothing to disclose.
Ariane Lewis, MD, F�鶹��ýӳ��	Dr. Lewis has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Seminars in Neurology. Dr. Lewis has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neuroscience.
Ibon Garitaonandia	No disclosure on file
Aaron Geller, MD	Dr. Geller has nothing to disclose.
Letizia G. Borges, MD	No disclosure on file
Christeena Kurian, MD	No disclosure on file
John Ko, PharmD, MS	Dr. Ko has received personal compensation for serving as an employee of Alnylam Pharmaceuticals. Dr. Ko has received personal compensation for serving as an employee of Novartis. Dr. Ko has received stock or an ownership interest from Alnylam Pharmaceuticals. Dr. Ko has received stock or an ownership interest from Novartis.
Noa Bregman	Noa Bregman has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Medison. The institution of Noa Bregman has received research support from Ionis pharmaceuticals.
Robert McInnis, MD	Dr. McInnis has nothing to disclose.
Jessie Huang	No disclosure on file
Carla E. Santiago-Martinez	Ms. Santiago-Martinez has nothing to disclose.
Omar M. Hussein, MD	No disclosure on file
Arielle Davis, MD, F�鶹��ýӳ��	Dr. Davis has nothing to disclose.
Henry Houlden	No disclosure on file
Phaedra M. Dowell, MD	No disclosure on file
Anat Mirelman	Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Abbvie . Anat Mirelman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Bial. The institution of Anat Mirelman has received research support from Department of Defense. The institution of Anat Mirelman has received research support from MJFF. The institution of Anat Mirelman has received research support from JPND. The institution of Anat Mirelman has received research support from EU-Horizon 2020.
Stephen Wright	No disclosure on file
Kelsey McDermott	No disclosure on file
David Brassat, MD, PhD	No disclosure on file
Syed A. Shah, MD	Dr. Shah has nothing to disclose.
Aiesha Ahmed, MD, MBA, F�鶹��ýӳ��	Dr. Ahmed has stock in Doximity.
Anton Vladic, MD	No disclosure on file
Rodolfo Gonzalez	No disclosure on file
Nidhi Kapoor, MD, MBBS, F�鶹��ýӳ��	Dr. Kapoor has nothing to disclose.
Priyanka Shekhawat, MD	Dr. Shekhawat has nothing to disclose.
Joong Hyun Park	Joong Hyun Park has nothing to disclose.
Antonio Gallo	Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sanofi. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Merck. Antonio Gallo has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Novartis.
Jessica A. Sagen, MA	Ms. Sagen has nothing to disclose.
Shashank Agarwal, MD, MBBS	Dr. Agarwal has nothing to disclose.
Erik Z. Krause, DO	No disclosure on file
Scott G. Turner, MD	No disclosure on file
Leonardo Almeida	No disclosure on file
Alexander Levit	No disclosure on file
Alexis M. Steinberg, MD	Dr. Steinberg has received research support from NIH.
Alessandro Orlando, MPH	No disclosure on file
Sara Razmjou-Schwarz, MD	No disclosure on file
Yuka Hama	No disclosure on file
Andrew Grzybowski, PhD	No disclosure on file
Troy Lund	No disclosure on file
Ali Hejazi, MD, PhD	No disclosure on file
Brian M. Andersen, MD	No disclosure on file
Michael DiSano, MD	No disclosure on file
Filippo Brighina, MD	Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Novartis. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for TEVA. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Prof. Brighina has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Alnylam Pharmaceuticals.
Brigida Fierro	No disclosure on file
Akanksha Sharma, MD	Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Generation Care Hospice. Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier . Dr. Sharma has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Curio Science. Dr. Sharma has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Jazz Pharmaceuticals. Dr. Sharma has received personal compensation in the range of $0-$499 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for MDPI. Dr. Sharma has or had stock in Roon. The institution of Dr. Sharma has received research support from Chimerix. The institution of Dr. Sharma has received research support from Novocure. Dr. Sharma has a non-compensated relationship as a Advisory Board with Elevate Med that is relevant to �鶹��ýӳ�� interests or activities.
Thomas J. Foutz, MD, PhD	No disclosure on file
Joshua Fulton, MBChB	No disclosure on file
Angelo Torrente	Mr. Torrente has nothing to disclose.
Namita Goyal, MD, F�鶹��ýӳ��	Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Argenx. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Annexon. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Abcuro. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Souffle. Dr. Goyal has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for CSL Behring. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Argenx. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amgen. The institution of Dr. Goyal has received research support from Fulcrum. The institution of Dr. Goyal has received research support from Healey Platform. The institution of Dr. Goyal has received research support from Medicinova. The institution of Dr. Goyal has received research support from Transposon. The institution of Dr. Goyal has received research support from Abcuro. The institution of Dr. Goyal has received research support from Calico. The institution of Dr. Goyal has received research support from Clene. The institution of Dr. Goyal has received research support from Janssen. The institution of Dr. Goyal has received research support from PepGen. The institution of Dr. Goyal has received research support from PTC. The institution of Dr. Goyal has received research support from Roche. The institution of Dr. Goyal has received research support from Sanofi. The institution of Dr. Goyal has received research support from Prilenia. The institution of Dr. Goyal has received research support from RAPA. The institution of Dr. Goyal has received research support from Avidity. Dr. Goyal has received publishing royalties from a publication relating to health care.
Martin Wilson, PhD	No disclosure on file
Rafael Arroyo Gonzalez	Rafael Arroyo Gonzalez has nothing to disclose.
Alessandro Meani	Alessandro Meani has nothing to disclose.
Caroline Miranda, MD	No disclosure on file
Shani Waninger, PhD	No disclosure on file
Irene V. Vargas	No disclosure on file
Jessica Bloomfield, MD	Dr. Bloomfield has nothing to disclose.
Ying Liu	No disclosure on file
Anup D. Patel, MD, F�鶹��ýӳ��	Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB Pharma. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lundbeck. The institution of Dr. Patel has received research support from PCORI. Dr. Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Webinar Development with Medscape. Dr. Patel has received personal compensation in the range of $500-$4,999 for serving as a Other capacity with Guidepoint. Dr. Patel has a non-compensated relationship as a Chair Quality Committee with �鶹��ýӳ�� that is relevant to �鶹��ýӳ�� interests or activities. Dr. Patel has a non-compensated relationship as a Committee Member with Child Neurology Society that is relevant to �鶹��ýӳ�� interests or activities. Dr. Patel has a non-compensated relationship as a Board of Directors - member with �鶹��ýӳ�� Institute that is relevant to �鶹��ýӳ�� interests or activities.
Mohammed H. Alkuwaiti, MD	No disclosure on file
Shawn Whitehead	No disclosure on file
Paulo E. Carrilho, MD, F�鶹��ýӳ��	No disclosure on file
Kyle C. Smith, DO	Dr. Smith has nothing to disclose.
Samuel Lichtman-Mikol, BA	Mr. Lichtman-Mikol has nothing to disclose.
Jennifer Guo	No disclosure on file
Filippo Savoldi, MD	No disclosure on file
Ahmed Enayetallah, PhD, MBBCh	Dr. Enayetallah has received personal compensation for serving as an employee of Alexion. Dr. Enayetallah has received stock or an ownership interest from Alexion. Dr. Enayetallah has received stock or an ownership interest from AstraZeneca.
Tridu Huynh	No disclosure on file
Luis Felipe Scarabelot	No disclosure on file
Ayman Alboudi, MD	Dr. Alboudi has nothing to disclose.
Eric J. Arehart, MD	No disclosure on file
Kamal Shouman, MD	Dr. Shouman has nothing to disclose.
Laura Vacchi	No disclosure on file
Xiaolan Ye, PhD	No disclosure on file
Ronald C. Siu, MBBS	No disclosure on file
Jean-Yves Richard	No disclosure on file
Rae E. Bacharach, DO	Dr. Bacharach has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for �鶹��ýӳ��.
Wijdan Rai, MBBS	Dr. Rai has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for EMD Serono. Dr. Rai has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics.
Karol Estrada, PhD	No disclosure on file
Craig Wakeford	No disclosure on file
Frank Wolters	No disclosure on file
Giorgio Giannattasio	No disclosure on file
Ravi YADAV, MD, DM	No disclosure on file
Andreia V. Faria, MD, PhD	No disclosure on file
Mohammad Aboulwafa	No disclosure on file
Peter E. Davis, MD	No disclosure on file
Tim Lachman, MD	No disclosure on file
Sneha Jacob, MD	Dr. Jacob has nothing to disclose.
Aishwarya Shukla	No disclosure on file
Lakshman N. Arcot Jayagopal, MD	Dr. Arcot Jayagopal has nothing to disclose.
Sandra M. Cushner Weinstein	No disclosure on file
Yuqi Qiu	No disclosure on file
Rwoof A. Reshi, MD	Dr. Reshi has nothing to disclose.
Matheus M. Peres, Sr.	No disclosure on file
Abhishek Lenka, MD, PhD	Mr. Lenka has nothing to disclose.
Sleiman El Jamal, MD	Dr. El Jamal has nothing to disclose.
Nicholas A. Jones, PharmD	No disclosure on file
Jaeho Kim	No disclosure on file
Viorica Chelban	No disclosure on file
Rosamaria Didiano	No disclosure on file
Elia Pestana-Knight	No disclosure on file
Tashfin Huq, MD	No disclosure on file
Harry Sutherland, MD	Dr. Sutherland has received publishing royalties from a publication relating to health care.
Yuji Takahashi, MD, PhD	The institution of Dr. Takahashi has received research support from Nihon Medi-Physics Co. Limit.. The institution of Dr. Takahashi has received research support from Takeda Pharmaceutical Company Limited.
Mona Ghadiri-Sani, MD, MBBS, BSc	No disclosure on file
Viren Patel, MD	No disclosure on file
Andrea Hildebrand	The institution of Ms. Hildebrand has received research support from National MS Society.
Ivan Cuesta Isabel, MD	No disclosure on file
Taha Nisar, MD	Dr. Nisar has nothing to disclose.
Barbara M. Decker, MD	Dr. Decker has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Neurelis.
Vidita Khatri, MD	No disclosure on file
Chuling Chen	No disclosure on file
Yulia Y. Orlova, MD, PhD	Dr. Orlova has nothing to disclose.
Doug Martini	No disclosure on file
Bhavani Kashyap, MBBS, PhD	Dr. Kashyap has nothing to disclose.
Chike Ilorah, MD, MPH	No disclosure on file
Loredana Storelli	Loredana Storelli has nothing to disclose.
Mark Wainwright, MD, PhD, F�鶹��ýӳ��	Dr. Wainwright has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sage Therapeutics.
Kerri LaRovere, MD	No disclosure on file
Regine Reimers, MD	No disclosure on file
Rachna Malani, MD	Dr. Malani has nothing to disclose.
Rossella Spataro	No disclosure on file
Milagros Hidalgo de la Cruz	Milagros Hidalgo de la Cruz has nothing to disclose.
Neil J. Patel, MD	Dr. Patel has nothing to disclose.
Craig A. Press, MD, PhD	Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Marinus Pharmaceuticals. Dr. Press has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Law Firms. Dr. Press has received research support from Marinus Pharmaceuticals. Dr. Press has received research support from Pediatric Epilepsy Research Foundation. Dr. Press has received research support from NIH.
J. Helen Cross	Dr. Cross has nothing to disclose.
Abdulla Alawadhi, MBBS	Dr. Alawadhi has nothing to disclose.
Lawrence Hewitt	Lawrence Hewitt has received personal compensation for serving as an employee of Lundbeck.
Vishwanath Sagi, MD, F�鶹��ýӳ��	Dr. Sagi has nothing to disclose.
Brandon Bond, MD	No disclosure on file
Andrew Ko	No disclosure on file
Atefeh Katrahmani	No disclosure on file
Ivie Tokunboh	No disclosure on file
Subhendu Rath, MBBS	Dr. Rath has nothing to disclose.
Toby A. Ferguson, MD	Dr. Ferguson has received personal compensation for serving as an employee of Biogen. Dr. Ferguson has received stock or an ownership interest from Biogen.
Saeyoan Thirunavukkarasu, MPH, MHA	No disclosure on file
Anna Ambrosini, MD	No disclosure on file
Rachel Marie E. Salas, MD, MEd, F�鶹��ýӳ��	Dr. Salas has received personal compensation for serving as an employee of HMPGlobal. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Neurology Learning Network. Dr. Salas has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for PRIME. Dr. Salas has received publishing royalties from a publication relating to health care.
Amir Besharat, DO	Dr. Besharat has nothing to disclose.
Daniella C. Sisniega, MD	Dr. Sisniega has nothing to disclose.
Wei-Ju Lee	Wei-Ju Lee has nothing to disclose.
Ketan Jhunjhunwala, MD	No disclosure on file
Harmehr Sekhon	No disclosure on file
Lamvy Le	No disclosure on file
Gabriel P. Lima, MD	Dr. Lima has received personal compensation for serving as an employee of Amgen Inc.
Tamra I. Ranasinghe, MD	Dr. Ranasinghe has nothing to disclose.
Sourav Santra	Sourav Santra has received personal compensation for serving as an employee of Sarepta Therapeutics.
Justine Moonen	No disclosure on file
Alexandra Basilakos, PhD	No disclosure on file
Phioanh L. Nghiemphu, MD, F�鶹��ýӳ��	Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Simpson Healthcare. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. Dr. Nghiemphu has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Springswork. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for CIRM. Dr. Nghiemphu has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Servier. Dr. Nghiemphu has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Springworks. The institution of Dr. Nghiemphu has received research support from Erasca. The institution of Dr. Nghiemphu has received research support from Springswork. The institution of Dr. Nghiemphu has received research support from Children's Tumor Foundation. The institution of Dr. Nghiemphu has received research support from NIH-NCI . The institution of Dr. Nghiemphu has received research support from DOD. The institution of Dr. Nghiemphu has received research support from GCAR.
Asha Das, MD, F�鶹��ýӳ��	No disclosure on file
Lisa M. Stropp, MD	No disclosure on file
Xiaodong Luo	Xiaodong Luo has received personal compensation for serving as an employee of Sanofi. An immediate family member of Xiaodong Luo has received personal compensation for serving as an employee of Beigene. Xiaodong Luo has stock in Sanofi. An immediate family member of Xiaodong Luo has stock in Beigene. An immediate family member of Xiaodong Luo has stock in Johnson and Johnson.
Basim M. Uthman, MD, FACIP, F�鶹��ýӳ��	No disclosure on file
Cassie Jia	No disclosure on file
Patrick Drummond, MD	Dr. Drummond has nothing to disclose.
Korhan Buyukturkoglu, PhD	Dr. Buyukturkoglu has nothing to disclose.
Lekha Pandit	Lekha Pandit has nothing to disclose.
Bradley Elder	Bradley Elder has nothing to disclose.
Mariane de Moraes Monteiro	No disclosure on file
Christopher Lock, MD, MBBS, PhD	Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Amgen. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Amgen. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Turning Point Litigation. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for Goodell, DeVries, Leech & Dann, LLP. Dr. Lock has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for McQuaide Blasko Attorneys at Law. Dr. Lock has received personal compensation in the range of $500-$4,999 for serving as an Expert Witness for BENNETT BIGELOW & LEEDOM P.S. .
Rebekah G. Langston	Ms. Langston has nothing to disclose.
Jessie Gibson, PhD, NP	No disclosure on file
Caitlin Bell	No disclosure on file
Claudio A. Osorio, MD	No disclosure on file
Matthew Hall	No disclosure on file
Jennifer L. Griffith, MD	No disclosure on file
Reena Gottesman, MD	Dr. Gottesman has nothing to disclose.
Mahsa Khayat-Khoei, MD	The institution of Dr. Khayat-Khoei has received research support from The National MS Society of America, for Fellowship Award.
Haruo Nakayama	The institution of Haruo Nakayama has received research support from JSPS.
Oscar Fernandez	No disclosure on file
Edward Labin, MD	Dr. Labin has nothing to disclose.
Dana S. Cooper, MD	No disclosure on file
Eric J. Eross, DO	No disclosure on file
Harsh Bhardwaj, DNB	No disclosure on file
Daniel H. Whittam, MBBS	No disclosure on file
Monisha Sachdev	No disclosure on file
Stephen H. Pasternak, MD, PhD	Dr. Pasternak has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Lilly. Dr. Pasternak has stock in Zywie Bio LLC. The institution of Dr. Pasternak has received research support from Zywie Bio LLC. Dr. Pasternak has received intellectual property interests from a discovery or technology relating to health care.
Mamdouh H. Kalakatawi, MD, F�鶹��ýӳ��	No disclosure on file
Ali A. Al-Mubarak, MD	No disclosure on file
Ghadah H. Altowaijri, MD	No disclosure on file
Eduardo W. Cortez-Garcia, DO	Dr. Cortez-Garcia has nothing to disclose.
Hussein Al Gahtani	No disclosure on file
Mousa A. Almejally, MD	No disclosure on file
Chu-Yueh Guo, MD	Dr. Guo has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics.
Abdulrahman O. Almalki, MD	No disclosure on file
Kasun I. Navarathna, MD	Dr. Navarathna has nothing to disclose.
Mary Comeau	No disclosure on file
Yong-Bum Song, PharmD	Dr. Song has nothing to disclose.
Sadaga H. Alawi, MD	No disclosure on file
Shireen Al-Qureshi, MD, FRCPC, F�鶹��ýӳ��	No disclosure on file
Sanjay N. Rakhade, MBBS, PhD	Dr. Rakhade has received personal compensation for serving as an employee of Alexion Pharmaceuticals . Dr. Rakhade has stock in Alexion Pharmaceuticals. Dr. Rakhade has stock in Astra Zeneca. Dr. Rakhade has received intellectual property interests from a discovery or technology relating to health care.
Abid Kareem	No disclosure on file
Reem Deeb, MD	No disclosure on file
Aimee A. Sato, MD	Dr. Sato has nothing to disclose.
Chelsea Zhu	No disclosure on file
Nycole K. Joseph, MD	No disclosure on file
Carolina R. Silveira, PhD	Carolina Silveira has nothing to disclose.
Jessica P. Ng, MD	Dr. Ng has nothing to disclose.
Dennis J. Dlugos, MD	Dr. Dlugos has received research support from NIH. The institution of Dr. Dlugos has received research support from The Epilepsy Study Consortium.
Massimo Zeviani, MD, PhD	No disclosure on file
Nagayama Shigemi, MD, PhD	No disclosure on file

�鶹��ýӳ��

�鶹��ýӳ��